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Summary
Singapore’s unique multiracial population structure and differential incidence and
mortality due to CAD in the ethnic groups provide an excellent opportunity to
explore further the etiological factors in coronary artery disease. In the study
leading to this thesis, polymorphisms in the GlycoproteinIIIa PIA1/A2, Factor XIII
(V34L) and mitochondrial( 5178C>A) genes were investigated in relation to coro-
nary artery disease among the Chinese, Malay and Indian ethnic groups in Sin-
gapore. Factor XIII V34L was studied in relation to plasma Factor XIII activity
and the mitochondrial variation in relation to plasma lipid levels. The genotypic
distribution of all the three polymorphisms were in accordance to a population at
Hardy Weinberg equilibrium.
The GpIIIa PIA2 allele has a significantly higher frequency among Indians relative
to the Chinese and Malays in Singapore. The effect of this genotype may par-
tially explain the higher rate of CAD seen among the Indians, which could not
be explained by traditional risk factors such as cigarette smoking, blood pressure
and serum cholesterol. According to the study the possible association of the PIA2
allele with CAD among the Indians is independent of the effects of smoking.
viii
Summary ix
The Factor XIII L34 allele is significantly higher among the Asian Indians than the
Chinese and Malays. The study shows that plasma FXIII activity is determined
by both ethnic and genetic components. The mean FXIII levels are significantly
higher among the Asian Indians when compared to the Chinese. The V34L poly-
morphism explains 13% of the total variation of FXIII activity among the female
Indians. No significant difference in the frequency of the L34 variant is observed
with subjects who have documented evidence of myocardial infarction. Although
there is a clear effect of FXIII V34L genotype on the FXIII specific activity, a di-
rect correlation between the V34L genotype and its activity in relation to coronary
artery disease was not observed.
Significant ethnic variations in allele frequencies were observed in this first study
of the mtDNA 5178C>A variation in the Asian populations outside Japan. The
polymorphism is associated, in an ethnic group and gender-specific manner with
plasma apoB levels in the Singaporean Chinese males.
Together, the study provides the allele frequency distribution of the nucleotide
variations in three candidate genes for coronary artery disease among the three
ethnic groups of Singapore. The results have also given valuable insights into the
relation of the V34L polymorphism to Factor XIII activity and that of mtDNA
5178C>A variation with plasma lipid levels. Evidence need to be integrated from
more studies which are being published in various ethnic groups for these candidate
genes. Also, there is a need to identify the functional effects of these polymorphisms
on protein function to better understand the results seen in the association studies.
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Chapter 1
Introduction to Coronary Artery Disease
1.1 Definition of coronary artery disease
Ischemic heart disease is the generic designation for a group of closely related
syndromes resulting from myocardial ischemia resulting from an imbalance between
oxygen demand and blood supply. Ischemic heart disease (IHD) is the predominant
cause of disability and death in all industrialized nations. In more than 90% of
cases, the cause for myocardial ischemia is reduction in coronary blood flow because
of atherosclerotic coronary lesions. Thus IHD is also termed coronary artery disease
(CAD).
1.2 Prevalence of coronary artery disease
CAD in its various forms is the leading cause of death in the industrialized nations
and accounts for about 80% of all cardiac mortality. Annually, about 5 million in-
dividuals are diagnosed as having IHD, resulting in approximately 600,000 deaths
every year (Cotran, Kumar and Robbins,5th ed). The frequency of IHD has pro-
gressively increased in most industrialized nations to almost epidemic proportions.
1
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In recent years, CAD has become more and more prevalent and is one of the prin-
cipal causes of deaths in eastern and/or developing countries. Since 1960’s the
death rate from IHD began to fall in the United States and elsewhere. Since 1968,
the overall mortality has fallen in the United States by almost 40% (Kirshenbaum,
1992). A similar welcome trend has occurred in Switzerland, Italy, New Zealand,
Australia, Belgium, Canada and Finland but not in Sweden, Denmark, Russia and
most East European countries. In Singapore, CHD accounted for 19.1% of total
deaths in 1994 and 92.1 people per 100, 000 died of CHD in the same year (Report
on Registration of Births and Deaths, 1994). The mortality rate from CHD in
China for the year 1990 was 47.5 per 100, 000 and 22.8 per 100, 000 for urban and
rural areas, respectively (Yao et. al., 1993). In India, a survey on urban Delhi
residents aged 25-64 years showed that the prevalence of CHD was 96.7 people per
1000 (Chadha et. al., 1990).
There are vast differences of CHD morbidity and mortality in different age groups,
genders and races. Men uniformly have higher incidence than women throughout
life. The CHD mortality in men is also higher (Lerner and Kannel, 1986). The
incidence and mortality of CHD also increases with age. The data from National
Center for Health Statistics showed that incidence of CHD dramatically increases
in men over 45 years and in women over 55 years. The proportion of CHD deaths
increased from 12% in men aged 35-44 years to 27% in men aged 65-74 years and
from almost 1% to 23% in women between the corresponding age groups (National
Center for Health Statistics, 1989).
Various races often demonstrate varying degree of morbidity and mortality from
CHD. In the United States, a 20-year follow-up study revealed that male blacks
had less hazard of CHD mortality than male whites, while female blacks exhib-
ited an equal or higher rate than that of their female white counterparts (Hames
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et. al., 1993). The 10-year follow-up MONICA project (multinational monitor-
ing of trends and determinants in cardiovascular disease) revealed that the age-
standardized annual event rate for CHD in middle-aged men was 915 per 100,000
for North Karelia, Finland, while it was only 76 per 100,000 for Beijing, China
(WHO MONICA project, 1994). In Trinidad (West Indies), a 10-year prospective
survey showed that the incidence of the first CHD event was 16.4 per 1000 person-
years in men of Indian origin, 6.8 per 1000 in men of African origin, 6.5 per 1000 in
those with European origin and 2.4 per 1000 in men with mixed origin (Miller et.
al., 1989). In Asia, Japanese have been found to have low incidence and mortality
for CHD (Uemura and Pisa, 1988). The incidence of CHD in Korea was as low as
8.5 per 100,000 in 1989 (Tchai, 1993).
The Indians in Singapore have much higher mortality of CHD compared with the
ethnic Chinese and Malays, irrespective of age and gender (Hughes, 1990b). For
example, the death rate from CHD for the years 1987-1994 in Singapore was 89.7
to 97.8 per 100,000 and CHD death accounted for 18.1-19.1% of total deaths (Re-
port on Registration of Births and Deaths, 1987-1994). However, the death rate
from CHD in 1994 was 177.7, 111.6, 84.2 per 100,000 population in the ethnic
Indians, Malays and Chinese, respectively. The death from CHD accounted for 30-
35%, 21.4-23.6%, 15.2-17.2% of total deaths for the years 1989-1994 in the ethnic
Indians, Malays and Chinese, respectively.
1.3 Pathogenesis and risk factors of coronary artery
disease
The dominant influence in the causation of the IHD syndromes is diminished coro-
nary perfusion relative to myocardial demand. There is presumed to be a complex
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dynamic interaction among fixed atherosclerotic narrowing of the epicardial coro-
nary arteries, intraluminal thrombosis overlying a disrupted atherosclerotic plaque,
platelet aggregation and vasospasm. Atherosclerotic narrowing of the coronary ar-
teries constitutes the primary factor responsible for the high morbidity and mor-
tality from coronary artery disease. Over 90% of the patients with one of the
ischemic heart syndromes have the advanced coronary atherosclerosis with one or
more stenotic lesions causing at least 75% reduction of the cross sectional area of
at least one of the major subpericardial arteries. The reduction will block the aug-
mented coronary flow needed to meet even the moderate increases in myocardial
demand. In general, about one third of the patients have single-vessel, another
third have two-vessel, and slightly more than a third have three-major-vessel dis-
ease.
1.3.1 Fatty streaks and the atheromatous plaque
The fatty streaks are precursors of atheromatous plaques. They are composed of
lipid-filled foam cells with T lymphocytes and extracellular lipid present in smaller
amounts than in plaques. Fatty streaks appear in the aortas of some children
younger than one year of age and all children older than 10 years regardless of ge-
ography, race, sex or environment. Coronary artery fatty streaks are less common
than aortic but they begin to form in adolescence at the same anatomic sites that
are later prone to develop plaques. Fatty streaks are related to the known risk
factors of atherosclerosis in adults (especially serum lipoprotein cholesterol con-
centrations and smoking). Though fatty streaks may be precursors of plaques, not
all fatty streaks are destined to become fibrous plaques or more advanced lesions.
The American Heart Association classification divides atherosclerotic lesions into
six types, beginning with isolated foam cells through stages of fatty streaks, athero-
mas and fibroatheromas to the complicated lesions (Stary et. al., 1995)(Table 1.1).







American Heart Association classification of atherosclerotic lesions 
Nomenclature and main histology Sequence in progression Main growth mechanism Earliest onset Clinical 
correlation 
Type1 ( initial lesion) I 
From 1st decade 
 
Type 2 ( fatty streak) lesion 
 
II 
Type3 ( intermediate) lesion III 
Clinically silent Growth mainly by lipid 
accumulation 




Type 5 ( fibroatheroma lesion) V 
Accelerated smooth muscle 
and collagen increase 
Type 6 ( Complicated lesion) VI Thrombosis, Hematoma 
From 4rth  
decade 
Clinically silent or 
overt 
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The atheromatous plaque consists of a raised focal plaque within the intima of
the vessel, having a core of lipid (mainly cholesterol and cholesterol esters) and a
covering fibrous cap. The lipid-core contains numerous lipid-loaded foam cells orig-
inating from macrophages and smooth muscle cells, and an extracellular lipid-pool
which contains cholesterol, cholesterol ester, lipoprotein (a) (Cushing et. al.,1989;
Rath et. al., 1989) and oxidized low density lipoprotein (LDL) (Yla-Herttuala et.
al., 1989 ; Rosenfeld et. al., 1991). Other components found inside the plaque
include collagen, proteoglycans (Wight, 1989), fibrin (Smith et. al., 1979; Bini et.
al., 1989), T-lymphocytes (Libby and Hansson, 1991) and complement components
(Seifert and Kazatchkine, 1988). Atheromas in advanced disease undergo patchy
or massive calcification. Focal rupture or gross ulceration or both of the luminal
surface of atheromatous plaques may result in exposure of highly thrombogenic
substances that induce thrombus formation or discharge of debris into the circula-
tion, producing microemboli. Haemorrhage into a plaque may occur from rupture
of either the overlying fibrous cap or the thin-walled capillaries that vascularize
the plaque. Superimposed thrombosis usually occurs on disrupted lesions (those
with rupture, ulceration or hemorrhage). Thrombi may partially or completely
occlude the lumen; they may become incorporated within the intimal plaque by
organization.
1.3.2 Fixed coronary obstruction and atheroma formation
More than 90% of the patients with IHD have coronary atherosclerosis. Most
but not all have one or more lesions causing at least 75% of reduction of the
cross sectional area of at least one of the major epicardial arteries. The onset of
symptoms and prognosis of IHD is dependent not only on the extent and severity
of fixed disease but also critically on the dynamic changes in coronary plaque
morphology.
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1.3.3 Acute plaque change and coronary thrombus
In most patients the myocardial ischemia underlying the acute coronary syndromes
are precipitated by abrupt plaque change followed by thrombosis. Often, the ini-
tiating event is the disruption of partially stenosing plaques with hemorrhage into
atheroma or rupture or fissuring of the plaque. The structure and composition of
the plaque are dynamic and may contribute to the propensity of disruption (Libby,
1985, Davies, 1996). Plaque disruption and ensuing platelet aggregation and in-
traluminal thrombosis are common. It is also responsible for the clinically silent
complications of atheroma. Healing of subclinical plaque disruption and overlying
thrombus comprises an important mechanism of growth of atherosclerotic lesions.
Partial or total thrombosis associated with a disrupted plaque is critical to the
pathogenesis of acute coronary syndromes. Due to the location of the plaque in
the arteries where the blood shear stress is irregular, the turbulence generated is
adequate to rupture the fragile plaque which is often rich in lipids (Richardson
et. al., 1989). Alternatively, intraplaque hemorrhage may blow out the plaque
cap (Falk, 1992). Following plaque rupture, subendothelial collagen fibrils, fi-
bronectin and von Willebrand factors initiate platelet aggregation. On the other
hand, thrombotic factors residing on the surface of macrophages and SMCs is ex-
posed or expressed (Bevilacqua et. al., 1985). Extrinsic pathway is initiated, which
finally leads to the formation of thrombin. Thrombin converts soluble fibrinogen
into insoluble fibrin and promotes polymerization of fibrin. In addition, thrombin
also promotes platelet aggregation and thus amplifies the thrombus formation.
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1.4 Central events in atherogenesis
1.4.1 Response to injury hypothesis
Atherogenesis involves the development of focal regions of chronic endothelial in-
jury, with resultant endothelial dysfunction such as increased endothelial perme-
ability and increased leukocyte adhesion. There is an insudation of lipoproteins
into the vessel wall, mainly LDL with its high cholesterol content and very low
density lipoproteins (VLDL) and modification of such proteins by oxidation. The
major steps involved include the adhesion of blood monocytes to the endothelium,
followed by migration of monocytes into the intima and their transformation into
macrophages and foam cells. The adhesion of platelets to focal areas of denudation
or to adherent leukocytes is followed by release of factors from activated platelets,
macrophages or vascular cells that cause migration of smooth muscle cells from
the media into the intima. There is a proliferation of smooth muscle cells in the
intima and elaboration of extracellular matrix leading to accumulation of collagen
and proteoglycans associated with enhanced accumulation of lipids both within
cells (macrophages and smooth muscle cells) and extracellularly.
1.4.2 Endothelial injury
Repetitive endothelial injury is the basis of ”response to injury hypothesis”. Non
denuding endothelial dysfunction and activation is manifested by increased en-
dothelial permeability, enhanced leukocyte adhesion and alterations in expression
of endothelial gene products. E.g. the endothelial adhesion molecules such as
ICAM-1 and VCAM-1 are expressed in the luminal endothelium overlying devel-
oping plaques and are thought to mediate the adhesion of circulating monocytes
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and lymphocytes during their early entry into the plaque. (Cybulsky and Gim-
brone, 1991; O’Brien et. al., 1996). The two important determinants of endothelial
dysfunction acting in concert are the hemodynamic disturbances that accompany
normal circulatory function and the adverse effects of hypercholesterolemia. The
turbular flow patterns with variable levels of shear stress cause focal areas of en-
dothelial dysfunction. The alteration of shear stress associated with disturbed flow
induces numerous endothelial genes with potential proinflammatory and proathero-
genic activities, including cytokines, adhesion molecules and coagulation proteins
and can cause increased endothelial permeability and cell turnover and enhanced
receptor-mediated LDL endocytosis (Gimbrone et. al., 1997). Based on in vitro
studies it has been postulated that the laminar shear stress typically encountered
in lesion-protected areas of the arterial vasculature induce endothelial genes whose
products actually protect from the development of lesions (Gimbrone et. al., 1997)
These ’atheroprotective’ genes could explain the nonrandom localization of early
atherosclerotic lesions.
1.4.3 Hyperlipidemia
Chronic hyperlipidemia may itself impair endothelial function. This is thought to
be mediated through the increased production of superoxide and other oxygen free
radicals that deactivate nitric oxide, the major endothelial relaxing factor. Oxida-
tive stress also activates the endothelial gene expression of numerous biologically
active molecules. With chronic hyperlipidemia, lipoproteins accumulate within the
intima at sites of increased endothelial permeability. The oxidative modification of
lipid by free radicals generated in the macrophages or endothelial cells in the arte-
rial wall yields oxidized LDL (Steinburg, 1997). Oxidized LDL is readily ingested
by macrophages through the scavenger receptor which is distinct from the LDL re-
ceptor, thus forming foam cells. Oxidized LDL is also chemotactic for circulating
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monocytes; it increases monocytes adhesion, inhibits the motility of macrophages
already in the lesions and stimulates release of growth factors and cytokines. Oxi-
dized LDL is also cytotoxic to endothelial cells and smooth muscle cells and is also
immunogenic, inducing the production of antibodies to oxidized lipoproteins. The
concept of hyperlipidemia leading to lesion formation through oxidative stress on
endothelium is consistent with experimental and clinical studies. (Treasure, 1995)
1.4.4 Other factors
Macrophages have a multifactorial role in the progression of atherosclerosis owing
to their large number of secretory products and biologic activities. The specific
endothelial adhesion molecules induced on the surface of activated endothelial cells
adhere the monocytes to the endothelium early in atherosclerosis. The monocytes,
following subendothelial localization become transformed into macrophages and
engulf lipoproteins, largely oxidixed LDL to become foam cells. Smooth muscle
cell proliferation and extracellular matrix deposition in the intima are the major
processes that convert a fatty streak into an atheromatous lesion resulting in the
progressive growth of atherosclerotic lesions. The monoclonal hypothesis of athero-
genesis implicates smooth muscle cell proliferation as the primary event leading to
the development of the atheromatous plaque. Recent data indicate that such mon-
oclonal populations result from patches of preexisting clones of cells (Murry et.
al., 1997). Chlamydia pneumoniae has been demonstrated in the atherosclerotic
plaques but not in normal arteries. It has been demonstrated that antibiotic ther-
apy for the organism reduces recurrent clinical events in patients with ischemic
heart disease (Gupta et. al., 1997). Also, studies have shown that certain viruses
cause arteritis in mice lacking interferon- gamma responsiveness (Weck et. al.,
1997).
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1.5 Conventional risk factors of coronary artery
disease
The risk factors that predispose to the atherosclerosis and resultant ischemic heart
disease have been identified in several prospective studies in well defined population
groups( Kannel and Wison, 1995). The method of establishing risk factors is one
way to explore the etiology of multifactorial diseases such as CAD. The main
character of a risk factor is that it is quantitatively and independently related
to the disease studied, while its elimination or decrease can reverse the condition
of the disease. Over past several decades, epidemiological studies have provided
numerous evidences to establish the following risk factors of CAD:
1.5.1 Age and hypertension
Death rates from CAD rise with each decade even into advanced age. From age 40
to 60 years there is a greater than five-fold increase in the incidence of myocardial
infarction. Atherosclerosis is a slowly progressive disease that begins in childhood
and develops slowly over decades (McGill et. al., 2000). Though a major risk
factor at all ages, hypertension is a stronger risk factor than hypercholesterolemia.
Studies have shown that increased death rates are associated with systolic blood
pressure greater than 100mm Hg and diastolic pressure greater than 70 mmHg.
1.5.2 Hyperlipidemia
Hyperlipidemia is acknowledged to be a major risk factor for atherosclerosis. The
major evidence implicating hypercholesterolemia in the genesis of atherosclerosis
includes the following:
• Genetic defects in lipoprotein metabolism causing hyperlipoproteinemia are
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associated with accelerated atherosclerosis. Familial hypercholesterolemia is
caused by defects in the LDL receptor. A single amino acid substitution in the
receptor binding site of the apoE molecule( Arginine to Cysteine at residue
158) reduces the binding activity to 1 to 2% of the normal, the genetically
variant apoE fails to bind properly to the LDL receptor. Mutations produc-
ing defective apoB cause similar binding abnormalities, resulting in increased
serum LDL. There is also evidence that genetic polymorphism in other nu-
merous genes involved in cholesterol metabolism contribute to atherosclerosis
susceptibility. E.g. CETP gene variations.
• Though no single level of plasma cholesterol identifies those at risk of CAD,
many large scale epidemiologic studies have demonstrated significant corre-
lation between the severity of atherosclerosis and the levels of total plasma
cholesterol or LDL. Atherosclerosis events are uncommon with total serum
cholesterol levels below 150 mg/dl.
• There is a major decline in the rate of progression of the disease when the
levels of serum cholesterol are lowered by diet or drugs, resulting in the low-
ering of the risk for CAD (Gotto et. al., 1997). Cholesterol lowering increases
overall survival risk and reduces risk of atherosclerosis related events in pa-
tients with established coronary heart disease with elevated (Scandinavian
Simvastatin Survival Study,1994) or average( Sacks et. al., 1996) cholesterol
levels as well as in patients with hypercholesterolemia but without overt
atherosclerosis-related disease. (Shepard et. al., 1995).
• Transgenic mice with genetic abnormalities of lipid metabolism develop atheroscle-
rosis with cholesterol feeding (Breslow, 1996).
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1.5.3 Cigarette smoking and diabetes mellitus
Cigarette smoking is a well established risk factor in the development of CAD. A
number of epidemiological studies have identified smoking as a major risk factor
for CAD (Shaper et. al., 1987; Keil et. al., 1993). Animal and in vitro experiments
showed that the endothelium was injured due to smoking (Pittilo et. al., 1990).
Necropsy detection also provided supportive evidence. Furthermore, cessation of
smoking was found to be correlated with decreased CAD risk (Hermanson et.
al., 1988; Ockene et. al., 1990). It has long been noticed that diabetic patients
have much higher risk for CAD. Some studies showed that the CAD mortality
accounted for more than one third of total deaths in diabetic patients (Fox et.
al., 2004). Although diabetic patients often have other CHD risk factors such as
obesity, hypertension, hyperlipidemia and elevated fibrinogen, diabetes mellitus
still remained an independent risk factor for CAD after these risk factors were
taken into account. (Barrett-Connor, 1985).
1.5.4 Genetic factors
The familial predisposition to CAD is well established. The polygenic inheri-
tance seen involves well defined hereditary genetic derangements in lipoprotein
metabolism that result in high blood lipid levels, as in familial hypercholesterolemia.
In other instances the genetic predisposition seen relates to familial clustering of
other risk factors such as hypertension and diabetes.
1.5.5 Hemostatic and thrombotic factors
Several markers of hemostatic and thrombotic function are potent predictors of
risk for major atherosclerotic events. The markers include those related primarily
to fibrinolysis and inflammation such as elevated levels of plasminogen activator
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inhibitor-1, plasma fibrinogen and C reactive protein, respectively. Studies have
shown that CRP levels predict the risk of myocardial infarction and stroke (Ridker
et. al., 1997a). Other factors associated with IHD risk include lack of exercise,
lifestyle, weight gain etc. Epidemiologic studies also indicate a protective role for
moderate intake of alcohol.
1.6 Genetic basis of coronary artery disease
It is well known that genetic factors play an important role in the etiopathogen-
esis of CAD and contribute to the individual’s susceptibility or resistances to the
disease. It was evident decades ago that the population distribution of cholesterol
levels is influenced by genes (Mayo and Stamatoyannopolous, 1969). The applica-
tion of modern genetic techniques has resulted in the identification of polymorphic
markers that are involved in the normal regulation and function of the cardiovas-
cular system. It is now known that several risk factors or protective factors with
respect to cardiovascular diseases are strongly influenced by genes and it is now
possible to identify individual genes contributing to cardiovascular risk.
1.6.1 Genetic markers for coronary artery disease risk
Current attempts to identify single genes contributing to the susceptible state focus
on the candidate gene approach. With respect to atherosclerosis and IHD there
are several categories of candidate genes, such as genes whose protein products are
involved in -
• lipoprotein structure and lipid metabolism
• thrombogenesis, thrombolysis or fibrinolysis
• regulation of blood flow in coronary arteries
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• in regulation of blood pressure
• reverse cholesterol transport
• formation, regulation and growth of atherosclerotic lesions
• early development of coronary arteries.
1.6.2 Ethnic variation of prevalence and mortality of CAD
Vast variations of morbidity and mortality of CAD among different ethnic groups
have been widely reported around the world. Populations worldwide have very
different levels and presentations of CAD. Factors which are likely to contribute
to this include differences in behavior and lifestyle that expose populations to dif-
ferent levels of risk and differences in racial and ethnic heritage which determine
the genetic predisposition. Early identification of geographic differences in the ex-
tent of aortic lesions between ethnic groups residing in the same area date back to
1943 (Mukherjee and Tribedi, 1943). South Asians who migrate to Europe, North
America or other regions of the world have an incidence of CAD which exceeds the
incidence of the countries to which they have migrated. This suggests a gene envi-
ronment interaction that elicits the risk factors. In the Israeli civil servants study,
despite the unifying factors in terms of environment and nutrition major differ-
ences still persisted in risk factor distribution and CAD incidence rates ( Medalie
et. al., 1973b, Medalie et. al., 1973a). The age-adjusted incidence of myocar-
dial infarction in Yemenite Jews was 15.9 per 1000, which was in sharp contrast
to the incidence of 66.8 per 1000 in Jews of Yugoslavian origin (Medalie et. al.,
1973b). The findings indicate that Yemenite Jews, despite cultural, economical
and even dietary changes, remain relatively immune to coronary morbidity and
mortality even after living in Israel for three, four or five decades. Interestingly,
autopsy studies of fetuses and infants with different ethnic origins have revealed
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that intima and musculoelastic tissue are thicker in Ashkenazi (European) than in
Yemenite Jews (Vlodaver et. al., 1969). At such an early stage of life, the ethnic
variations have been quite evident, and these variations parallel the patterns of
CHD morbidity and mortality by ethnic groups. Another example is Asian Indian
population (South Asian). There are many consistent reports about unusually
high incidence and mortality of CAD in the Indians all over the world, from Singa-
pore, Mauritius, Trinidad, Fiji, Uganda, and South Africa to the UK. The earliest
report of high CAD rates in the Indians was from Singapore. The prevalence of
CAD, in 9568 autopsies during the period 1954-1957, was seven times higher in
the male Indians than in the Chinese. The age-standardized CAD death rate was
2-4 times higher in the Indians than in the Chinese (Danaraj et. al., 1959). About
30 years later, the CAD mortality analyses presented a similar picture. During
the period 1980-1984, Singaporean Indians had the highest mortality from CAD
among the three ethnic groups (Chinese, Malays and Indians) and the mortality
patterns were uniform in all the age groups. The age-standardized relative risk of
Indians vs. Chinese was 3.8, 3.4 in men and women, respectively (Hughes et. al.,
1990b). More recent mortality statistics have again confirmed the excess of CAD
in Singaporean Indians. The proportion of deaths arising from CAD for the year
1994 was 31.9%, 22.4% and 17.2% for the Indians, Malays and Chinese, respec-
tively (Report on Registration of Births and Deaths, 1994). Some cross-sectional
studies had indicated that some of the established risk factors for CHD, such as
TC, LDLC, hypertension and smoking, failed to explain in full the high excess of
CHD in Singaporean Indians (Saha 1987; Hughes et. al., 1990a). However, Indi-
ans in Singapore were found to have lower HDLC, apoA-I and raised Lp(a) levels
compared to the ethnic Chinese (Saha 1987; Sandholzer et. al., 1992). In South
Africa, during the period 1955-1957, the CHD mortality of Indian women aged
30-69 years was 49% above that of women with European origin (Adelstein, 1963).
1.6 Genetic basis of coronary artery disease 17
As in Singapore, the authors found that these ethnic differences could not be ex-
plained by the differences in systolic blood pressure, smoking or HDLC, LDLC and
fasting glucose levels (Beckles et. al., 1986). In England and Wales, the mortality
analyses for the years 1970-1972 showed that those immigrants, born in the Indian
subcontinent (India, Pakistan, Bangladesh and Sri Lanka), had the highest mor-
tality from IHD. Although the overall mortality from IHD remarkably declined
in England and Wales in the following decade, the ethnic Indians, however, ex-
perienced a mortality increment of 6% in men and 13% in women. It is obvious
that, regardless of the number of generations of Indian immigrants who lived in the
adopted countries and the geographic locations in the world, the Indian immigrants
from Indian subcontinent seem to keep a divergent CHD morbidity and mortality
from their compatriots of the host countries, although all of them share a common
environment and some degree of integration of dietary and cultural habits. Taken
together, the persistent low mortality of Yemenite Jews and the high mortality of
the Indians point to the possibility that ethnic difference of CHD is inherent in
their ethnic origin. In summary, there is therefore sufficient evidence to implicate
genetic factors as major determinants for the development of CHD.
1.6.3 Background of present study
Singapore is a multiracial republic represented by 77.5% Chinese, 14.2% Malays
and 7.1% Indians (Report on Registration of Births and Deaths, 1994). The de-
mographic data show that the ethnic Chinese are the second or third generation of
the early immigrants who came from Fujian and Guangdong provinces of China.
The ethnic Indians consist of 82% Southern Indians and 18% Northern Western
and Eastern Indians (Punjabis, Gujaratis and Bengalis). The immigrant Chinese
and Indians have lived together with native Malays for the past two to three gen-
erations, with shared socio-economic environment and to some extent integrated
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dietary habits. However, their incidence and mortality of CHD, as mentioned
above, are markedly different. The Chinese have the lowest mortality, while the
Indians have the highest mortality from CHD in both male and female (Report
on Registration of Births and Deaths, 1987-1994; Hughes et. al., 1990b). As
mentioned earlier, overseas Indians around the world have been widely reported
to have higher CHD death rate compared to their compatriots (Wyndham, 1982;
Tuomilehto et. al., 1984; Beckles et. al., 1986; McKeigue and Marmot, 1988a).
It has been observed that Indians have low levels of HDLC (Miller et. al., 1984,1988;
McKeigue 1985,1988b,1989; Saha, 1987; Hughes et. al., 1990a). The high preva-
lence of diabetes mellitus among Indians is well known (Zimmet et. al., 1983;
Balarajan et. al., 1984). These two points seem to be consistent with the high
incidence and mortality of CHD in the Indians. However, smoking is not always
more prevalent among the Indians (Silman et. al., 1985; McKeigue et. al., 1985,
1988b, 1989; Balarajan and Yuen 1986; Miller et. al., 1988; Sicree et. al., 1988).
Similarly, hypertension is not always more common in the Indians (Keil et. al.,
1980; de Giovanni et. al., 1983; Beckles et. al., 1986; Sicree et. al., 1988; Miller
et. al., 1988; McKeigue et. al., 1988b,1989). Total cholesterol levels in the Indians
were also not higher than those of the native people or migrants with other origins
(McKeigue et. al., 1985, 1988a, 1988b; Miller et. al., 1988; Hughes et. al., 1990c).
In Singapore, the ethnic Indians showed no difference in cholesterol level compared
to the Chinese and Malays (Saha 1987). In addition, studies in Singapore and
Malaysia showed that the Indians had high prevalence of CHD and this pattern
keeps uniform at any age group. The ethnic differences in CHD risk could not be
explained by conventional CHD risk factors like hypertension, smoking, hyperc-
holesterolemia and even diabetes mellitus (Saha et. al., 1973; Rajadurai et. al.,
1992). Although the Chinese have been reported to be at low CHD risk, their lipid
profiles are not optimal. The lipid profile in HongKong Chinese was not different
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from that of North Americans. Twenty one percent of male and 11% of female
Chinese had LDLC > 4.1 mmol/L (Lau et. al., 1993). In Singapore, the total
cholesterol levels in the ethnic Chinese were not different from that in the ethnic
Indians, in spite of a much lower CHD incidence in the ethnic Chinese (Saha, 1987).
Singapore’s unique multiracial population structure and differential incidence and
mortality of CHD in those ethnic groups provide an excellent opportunity to ex-
plore further the etiological factors of CHD. The Cardiovascular Genetics Research
Group (Department of Pediatrics, National University of Singapore) has exten-
sive experience in studying the genetic epidemiology of CAD in both adults and
neonates. Genetic epidemiological studies have been conducted on the local res-
idents as well as tribal populations in the region with the aim of elucidating the
effects of genetic polymorphisms on plasma CAD risk factors. The genes that have
been investigated by the group can be broadly classified under two categories, i.e.
lipoprotein genes and those coding for blood coagulating factors as shown in Table
1.2.
Our group has embarked on efforts to compile genotype information of individu-
als from all known polymorphisms. One of the objectives is to analyze these to
evaluate their usefulness in assessing an individual′s CAD risk. If discriminating
power is sufficient from these DNA markers, our database would then be used to
identify neonates or adults at high CAD risk so that preventive measures can be
implemented early in life.









Lipoprotein genes Polymorphisms 
 
Apolipoprotein (a) Kringle 4, Pentanucleotide repeats, + 93  
ApolipoproteinA-1 /C3 Promoter –75 & +83 
Apolipoprotein A-2 MspI at 3’ Alu sequence  
Apolipoprotein A-4 Apo-VI*1 to 4 
Apolipoprotein B Signal peptide insertion/deletion, antigens a1/d, c/g, h/i, t/z, x/y, XbaI 
Apolipoprotein E HhaI at Codon 112 & 158 
Apolipoprotein H APOH*1 to 4 
ATP-Binding Cassette 
Transporter (ABCA1) 
Promoter 14C>T, 5’ UTR 237indelG, Exon 17 V825I, Exon 18 M883I, 
3’UTR 8994A>G 









Factor VII Promoter –332, codon 353, Intron 7 VNTR  
Factor XIII P564L, E654Q 
Fibrinogen (a - gene) TaqI, codon 312  
Fibrinogen (b - gene) Promoter -455, -148, intron 1 at codon 1689, BclI 
Antithrombin III -345, Intron 5 at 160bp 
GpIIIa PIA1/A2 







Insertion/deletion in intron 16 
Paraoxonase PON A, PON B 
Haptoglobin Isoforms Hp1 and Hp2 
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In the present study, three genes (GpIIIa, FXIII and Mt DNA) were investigated
in relation to CAD. Since CAD seems to have genetic determinants, the genotype-
phenotype relationship was explored. The study determines the influence of geno-
types on the plasma levels of the lipid components and coagulation components






A total of 1283 healthy individuals undergoing routine annual medical exam-
inations were recruited to study the F13V34L polymorphism and the MtDNA
5178C>A polymorphism. They were recruited randomly from those who attended
routine medical examinations at the SATA(Singapore Anti-Tuberculosis Associa-
tion) Chest and Heart Clinic, which is a community clinic supported by charity. It
offers low-price medical screening tests. Physical examination and laboratory tests
such as blood hemoglobin estimation, urine analysis for albumin and sugar, chest
X-ray and resting electrocardiogram were carried out. Informed consent from all
the subjects was sought prior to their inclusion into the study. Information was also




2.1.2 Coronary artery disease patients
365 CAD patients belonging to 3 different ethnic groups in Singapore, namely
the Chinese, Malays and Indians, were genotyped to study the MtDNA 5178C>A
genetic polymorphism. CAD cases were admitted for coronary artery bypass graft
at the Singapore National Heart Center. They had more than 50% stenosis in at
least one of the major coronary arteries.
2.1.3 Random male individuals
The study recruited 706 random male individuals for studying the GpIIIa PIA1/A2
polymorphism. Subjects included for this study were drawn from those undergoing
routine annual medical examinations offered by their employers, at the Singapore
Anti Tuberculosis Association Chest and Heart Clinic. Physical examinations and
laboratory tests such as blood hemoglobin estimation, urine analysis for albumin
and sugar, chest X-ray and resting electro-cardiogram were carried out. Verbal
informed consent from all the subjects was sought prior to their inclusion into this
study. Information was also obtained regarding the personal and family medical
history, smoking and drinking habits through questionnaires.
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2.2 Chemicals and reagents
The following chemicals and reagents were used:
Polaroid film (667) - Kodak Co., Rochester, USA.
Berichrom FXIII kit - Behringwerke, AG, Marburg, Germany
SeaKem GTG agarose - Bio Whittaker Molecular Applications, Maine, USA
Restriction enzymes: NciI, DdeI, AluI -
New England Biolabs. Inc., Massachusetts, USA
HPLC purified oligonucleotides (primers) for PCR -
BST Scientific, 1st Base Pte Ltd, Singapore
Deoxynucleotide triphosphate (dNTP)mix -
Epicentre Technologies, Wisconsin, USA
DyNAzyme DNA polymerase, PCR buffer -
Finnzymes, Oy, Finland
EDTA, Absolute ethanol, MgCl2, Ammonium peroxodisulphate, NaCl,
Dimethylsulphoxide (DMSO), Boric acid
Merck, Darmstadt, Germany
N-lauroylsarcosine (sodium salt), Tris hydroxymethyl aminomethane,
Proteinase K, Guanidine, Sodium dodecyl sulphate (SDS, sodium
salt), pBR322 HaeIII digest (molecular marker)
Sigma Chemical Company, St. Louis, Missouri, USA
Phosphotungstic acid/magnesium chloride kit (for HDLC), CHOL as-
say kit for TC and HDLC, TRIG assay kit for Triglyceride
Roche Diagnostic Systems, Basel, Switzerland.
2.3 Instruments and general apparatus 25
2.3 Instruments and general apparatus
The following instruments and apparatus were used:
Ultracentrifuge -
Sorvall RC-5B. Du Pont Instruments, Connect. USA.
High-speed centrifuge -
KS-5000P. Kubota Corporation, Tokyo, Japan.
PCR amplifier -
DNA Thermal Cycler. Perkin Elmer Cetus, Boston, USA.
Electrophoresis power pack -
ECPS 3000/150.Pharmacia Fine Chemicals,Uppsala, Sweden.
Horizontal electrophoresis set -
electro-4 gel tank. Hybaid Ltd,USA.
Polaroid camera -
MP4 land camera. Kodak Co., New York, USA.
UV transilluminator -
chromato-VUE transilluminator, TS-15. UVP corporation,
Cambridge,United Kingdom.
Blood tube rotator -
SB1, Stuart Scientific Co. Ltd, Sterling, United Kingdom.
Biochemical autoanalyzer -
Cobas Mira. Roche Holding Ltd, Basel, Switzerland.
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2.4 Methods
2.4.1 Record of demographic information
After obtaining verbal consent, all the subjects were asked to fill in a questionnaire
form, which includes the following items: age, height, weight, race, smoking history,
use of oral contraceptives, medical history, and family history. The sample of the
questionnaire form is presented in the Appendix 1. Weight was measured by an
electronic weight and height machine. Height was measured by the same machines
with which weight was measured. The reading was taken to the nearest centimeter
(cm) with subjects standing straight without shoes. Body Mass Index (BMI) was
estimated by the formula: BMI = Wt(Kg)/Ht2(m2). The systolic and diastolic
blood pressures were recorded after the subjects were asked to rest for at least 30
min. A 12-lead electrocardiogram (ECG) was performed. Chest X-ray was also
taken.
2.4.2 Blood sampling
All the subjects were requested to fast overnight (at least 10 hr). Blood was
collected between 8 - 10 am after subjects had been seated for at least 30 min.
Blood samples were collected by direct venupuncture in vacutainer tubes [5 ml in
plain, 3 ml in EDTA, 4 ml in 3.8% trisodium citrate (9 parts of blood with 1 part of
coagulant)] using multisampling device with minimal stasis. Citrated plasma was
separated within one hour. Separation was carried out at 2800 rpm (revolutions
per minute) for 15 min at room temperature in a Kubota centrifuge and plasma was
aliquoted into three vials for the separate coagulation factor assays. The plasma
was snap-frozen in liquid nitrogen and then stored at -80 deg C until analyzed. At
the same time, blood was also separated by centrifuge and the serum was aliquoted
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into three tubes. The supernatant was obtained and two aliquots of serum were
stored at -70 deg C until analyzed. Packed cells were stored at -20 deg C for the
extraction of genomic DNA.
2.4.3 Measurement of blood lipids and coagulation factors
Serum Precipitation for HDLC Estimation:
Serum was first precipitated by a phosphotungstic acid/magnesium chloride kit.
Briefly, 500 ul of the reagent was added into 200 ul of serum. The mixture was
allowed to stand at room temperature for at least 10 minutes so that LDL and
VLDL would have enough time to precipitate with polyanions and magnesium
chloride. After centrifuging at 1000 rpm for 5 minutes, the mixture was separated
and the supernatant was used for the enzymatic estimation of HDLC.
Enzymatic Estimation for TC, HDLC and TG:
TC, HDLC and TG were detected by Cobas Mira autoanalyzer using correspond-
ing reagent kits supplied by manufacturers. The reaction principle is based on
peroxidase based enzymatic colorimetric assay.
Calculation of LDLC:
The concentration of LDLC was calculated according to the Friedewald equation
(Friedewald 1972): LDLC = TC - (HDLC + TG/5), where TC is total cholesterol,
HDLC is cholesterol contained in HDL particles and TG is triglyceride. Results
were calculated in milligrams per deciliter (mg/dl). Quality control for HDLC,
TC, and TG was verified routinely with the reference laboratory values (Wellcome
Quality Assurance Program, UK).
Measurement of Factor XIII Activity (FXIII):
Plasma FXIII activity was assayed by photometric assay [Fickenscher et. al., 1991]
using Berichrom FXIII kit (Behringwerke AG, Marburg, Germany). The percent-
age of FXIII activity was calculated against reference standard human plasma
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of known activity. Internal quality control was checked by including two control
plasma samples (normal and abnormal) in each batch of assay. Reference standard
and control plasma were supplied in the Berichrom FXIII kit.
2.4.4 Extraction of genomic DNA
The extraction of genomic DNA was followed according to the method described
by Parzer and Mannhalter,1991. Frozen packed blood cells, from 5 ml of whole
blood, were thawed at 37 deg C. Fifty ml of pre-chilled cell-lysis buffer (0.32 M
Sucrose, 5 mM MgCl2, 1% Triton-X-100 and 0.01 M Tris-HCl at pH 8.0) was added
into blood. The mixture was homogenized briefly in a polypropylene tube with an
electric homogenizer and then kept in ice for 10 min. After centrifuging at 6800g,
4 deg C for 10 min, the supernatant was discarded and the pellet was thoroughly
washed in 50 ml of washing buffer (10 mM NaCl/10 mM EDTA at pH 8.0). After
another cycle of centrifuging at 6300g, 4 deg C for 10 min, the pellet was mixed
with following reagents in the given order: 350 ul of sodium sarkosyl (20%), 250
ul of ammonium acetate (7.5 mM), 3.5 ml of guanidine (6 mM) and 100 ul of
proteinase K (10 mg/ml). The mixture was then incubated in a waterbath at 60
deg C for 20 -30 min until the solution became clear. The solution was then kept in
ice for 10 min to allow the temperature to drop to 0 deg C. Pre-chilled (-20 deg C)
absolute ethanol (8-10 ml) was subsequently added into the solution to precipitate
genomic DNA. A hooked glass rod was utilized to spool genomic DNA, which was
then dissolved in 100-300 ul of sterile water.
2.4.5 PCR and RFLP analysis
The PCR reaction was carried out in 20 ul of reaction mixture containing ap-
propriate amount of following reagents: genomic DNA, PCR buffer, two primers
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complementary to the 5’ and 3’ ends of DNA, MgCl2, four dNTPs, DMSO and
DyNAzyme DNA polymerase. Amplification was carried out in an automated
thermal cycler (Perkin Elmer Cetus, 480). The individual amplification conditions
are given in the respective chapters. PCR products (20ul) were digested overnight
with 5-10 units of appropriate restriction enzymes. The detailed amount of re-
striction enzymes and the incubation temperature for individual polymorphisms
are given in the method section of the respective chapters. Digested fragments of
PCR were size-fractionated by electrophoresis together with the molecular weight
marker (pBR322 HaeIII digest) in TBE buffer (0.45 M Tris, 0.45 M boric acid and
0.001 M EDTA) at 150-200V for approximately 30 min. The appropriate concen-
tration of agarose gel( SeaKem agarose) was used for individual polymorphisms.
The ethidium-containing agarose gel was placed over the UV transilluminator and
the size-fractionated bands were documented by Polaroid photography.
2.5 Statistical analyses
Distribution of genotypes:
Whether or not the distributions of genotypes of a polymorphism were at Hardy-
Weinberg equilibrium was detected by comparing the frequencies of genotypes
observed with those expected from the Hardy-Weinberg law (p2 +2pq +q2). If the
p value was bigger than 0.05, the null hypothesis that distribution of genotypes for
the investigated polymorphism was at Hardy-Weinberg equilibrium was accepted.
Allele Frequencies: The allele frequencies were estimated by direct gene counting,
which, in turn, reflected the frequencies of specific genotypes. Given two alleles A






where AA is the case number of genotype AA, AB is the case number of genotype
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AB and N is the total case number in the sample. The difference in allelic frequen-
cies between two healthy populations or between CHD patient groups and healthy








where p1 and p2 are allelic frequencies observed in population 1 and population
2, respectively. n1 and n2 are the allele number in the respective populations.
The value of z is assessed by referring to a table which relates z to the level of
significance.
Estimation of Linkage Disequilibrium:
The delta value (4) was used to evaluate the extent of linkage disequilibrium
between any pairwise combination of a few polymorphic loci within a gene. The
value was calculated following the method described by Hill and Robertson, 1968.
∆ =
g1g4 − g2g3√
(g1 + g2)(g3 + g4)(g1 + g3)(g2 + g4)
(2.3)
where gi = ni / n (i=1,2,3, 4) and n1, n2, n3 and n4 are the numbers of ++, +–,
– + and – – haplotypes observed in a sample of n chromosomes. The value is the
correlation coefficient between the uniting gametes at the two loci. This value is
= 0 when association between two loci is random and is = 1 when association is
complete, with a positive sign implying the common allele at one locus is associ-
ated with the common allele at the other locus whereas a negative sign implying
the common allele at one locus is associated with the rare allele at the other locus.
The value in this study was calculated using Microsoft Excel spreadsheet computer
program.
Pearson Chi-square Test:
Pearson chi-square test is often used to test whether two discrete variables are
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independent or associated. The chi-square statistic was calculated by summing





where O is the observed number and E is the expected number. The calculated
chi-square is then compared to the critical points of the theoretical chi-square dis-
tribution to check how likely or unlikely this calculated value is if the two variables
are in fact independent (i.e., not associated). It must be indicated that the chi-
square test provides little information about the extent, or form, or direction of
the association between the two variables. Chi-square value not only depends on
the goodness of fit of the independence model but also on the sample size. The
conditions for chi-square test include (1) samples are obtained randomly; (2) the
expected value must not be too small.
Tukey’s honestly significant difference (HSD) test:
“Honestly Significantly Different”(HSD) test proposed by the statistician John
Tukey is based on what is called the “studentized range distribution”. The test
is used to know exactly which means are different from each other. To test all
pairwise comparisons among means using the Tukey HSD, t is computed for each






where Mi - Mj is the difference between the ith and jth means, MSE is the Mean
Square Error, and nh is the harmonic mean of the sample sizes of groups i and j.
Analyses of Variance (ANOVA):
When the means of more than two groups were compared, the analyses of variance
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(ANOVA) was utilized in this study. However, ANOVA procedure requires two
basic assumptions. One is that each group is a random sample from a normal
population. Another one is that the variances of the groups are equal. Therefore,
the normality and equality of variance were examined prior to ANOVA. Log10-
transformation was thus introduced into the necessary variables. The ANOVA
technique first examined the variability of the observations within each group as
well as the variability between the group means. Based on these two estimates
of variability, an F ratio was calculated by dividing between-groups mean square
with within-group mean square. A null hypothesis that all the groups had equal
means was then tested. Significance level was based on both the actual F value
and the degree of freedom for the two mean squares. If p was less than 0.05, the
null hypothesis was rejected and a conclusion that these groups were of different
means was drawn. The coefficient of determination (R2) was also estimated during
the ANOVA procedure. R2 is an estimate of the extent to which variance in the
two variables is interdependent. In other words, R2 is the proportion of variation
of one variable (dependent factor) determined by the variation of the other (inde-
pendent factor). It was calculated by dividing sum of squares of the main effect
(independent factor) by the total sum of squares. R2 is conventionally expressed
as R2 X 100. The R2x100 value is often interpreted as the percentage of sample
variance (dependent factor) explained by an independent factor.
Chapter 3
The Platelet Glycoprotein IIIa PIA1/A2
Polymorphism
3.1 Introduction
Since traditional risk factors alone are unable to explain this increased risk seen
among Indians in Singapore for CAD, this study set out to examine the genetic
factors that may offer an explanation for this increased predisposition towards
development of CAD. One of these possible genetic variations is the polymorphism
of the glycoprotein receptor (GpIIb/IIIa) on platelets. Platelets play an integral
role in the pathogenesis of coronary thrombosis. GpIIb/IIIa binds fibrinogen and
allows platelets to form links that enhances platelet aggregation. GpIIIa is the
beta subunit of this receptor and is also found on the vitronectin receptor. A
single nucleotide T to C transition at position 1565 in Exon 2 of the gene encoding
GpIIIa leads to a common diallelic polymorphism Leu-33-Pro( Newman et. al.,
1989). Persons with the PIA2 allele therefore have a proline at this position while
patients with only the PIA1 allele have leucine at this position; the substitution
is associated with an increased binding of fibrinogen to the platelet GpIIb/IIIa
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receptor (Goodall et. al., 1999). The allele frequency of this polymorphism has
been well documented in Caucasian populations(Kim et. al., 1995; Weiss et. al.,
1996). However, there have been no studies examining this polymorphism among
the three major ethnic groups found in Singapore, namely the Chinese, Malays
and Asian Indians.
The study investigated the PIA2 allele frequency among the ethnic groups in Sin-
gapore and whether the differences in PIA1/A2 allele frequency could account for
the increased incidence of ischaemic heart disease seen among Indians.
3.2 Methods
3.2.1 Subjects
706 random male individuals were recruited from those attending routine annual
medical examinations offered by their employers at the SATA Clinic, according to
the guidelines mentioned in section 2.1.3. Subject demographics are as shown in
Table 3.1.
3.2.2 Laboratory procedures
Venous blood was taken from each subject after an overnight fast of at least 10
hours in tubes containing EDTA as anti-coagulant. Genomic DNA from blood was
extracted according the methods of (Parzer and Mannhalter, 1991). Polymerase
Chain Reaction was carried out in 20 microlitre reaction volumes with the primers
sense: 5’-tctgattgctggacttctctttg-3’and antisense: 5’-tctctccccgcaaagagtcc-3’. The
cycling conditions were as follows: 5 min denaturation at 94 deg C, followed by
34 cycles of 30 sec of denaturation at 94 deg C, 20 sec of annealing at 57 deg C
and 30 sec of extension at 72 deg C followed by a final 10 min extension step at
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Figure 3.1: Glycoprotein IIIa PIA1/A2 genotypes
72 deg C. Overnight digests were conducted with 5 U of the restriction enzyme
NciI (New England Biolabs) in 20 microlitre of amplicons. Digested products were
electrophoresed in 3.5% agarose gel and visualized under UV light by ethidium
bromide staining (Figure 3.1).
3.2.3 Statistical analyses
The chi-square analyses was used to test for Hardy-Weinberg equilibrium and the
z-test for differences in allele frequency between ethnic groups. A P value of 0.05
or less was considered to indicate statistical significance. Analyses was performed
using SPSS (version 11.0) statistical software (SPSS Inc, Chicago).
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3.3 Results
The genotypic distributions among the 3 major ethnic groups are shown in Table
3.2. The distribution was in accordance to a population at Hardy Weinberg equi-
librium. Among the 197 Indians studied, 159 were homozygous for the PIA1 allele,
36 were heterozygous (PIA1/A2) and 2 individuals were homozygous for the PIA2
allele. The PIA2 allele frequency was 10% in the Indians. This was significantly
higher than the Chinese and Malays for whom the PIA2 frequency was only 1%.
3.4 Discussion
The major finding of this study was the significantly higher prevalence of the PIA2
allele among Indians, which was approximately 10 times higher compared to the
Chinese. The PIA2 allele frequency among Indians in this study is close to those
in Caucasian populations(Kim et. al., 1995; Weiss et. al., 1996).
The marked difference in the frequency of the PIA2 allele between the ethnic Indi-
ans compared to the Chinese and Malays in Singapore may have important clinical
implications. Various studies have shown increased risk of coronary artery disease
in relation to the PIA2 allelic variant of the GpIIIa receptor. A case-control study
by Weiss and colleagues( Weiss et. al., 1996) found an association of the PIA1/A2
polymorphism with acute coronary thrombosis, particularly in patients who were
under the age of 60. The Framingham Offspring Study( Feng et. al., 1999) has also
demonstrated heightened platelet aggregability among patients with this polymor-
phism. Another study( Mikkelsson et. al., 2000) demonstrated a higher proportion
of the PIA2 allele among subjects presenting with sudden cardiac death and evi-
dence of acute coronary thrombosis on autopsy in Finland.
Investigators have also demonstrated that individuals with the PIA2 allele have a
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higher risk of restenosis after coronary stent placement and are also at a higher
risk of sub-acute coronary stent thrombosis( Kastrati et. al., 1999). Subjects who
possessed the PIA2 allele had a five-fold increase in the occurrence of coronary
stent thrombosis( Walter et al 1997). There have also been studies that failed to
demonstrate an association of coronary thrombosis with the PIA2 allele( Ridker
et. al., 1997b, Laule et. al., 1999) . However, a recent meta-analyses(Di Casteln-
uovo et. al., 2001) reviewing 34 studies for coronary artery disease and 6 studies
for re-stenosis after percutaneous intervention, (a total of 9095 cases and 12508
controls) found a significant but weak association of the PIA2 allele with overall
cardiovascular disease. Higher risks were identified however, among less hetero-
geneous subgroups mainly the young and for re-stenosis among patients who had
received percutaneous intervention and stent placement.
The increased prevalence of this allele among Indians could possibly contribute
towards their higher risk of developing coronary heart disease when compared to
their Chinese and Malay counterparts. To verify this suggestion, the incidence of
coronary artery disease among the Indians that were enrolled in the study were
estimated. It was found that more than 10% of the Indian subjects were having
CAD as against 4% and 2% among the Malays and Chinese, respectively. This
is despite the fact that 78% of the Indian subjects selected for the study were
non smokers as against 69% (Chinese) and 41% (Malays). As such, the possible
association of the PIA2 allele with CAD among the Indians is independent of the
effects of smoking. A subset of subjects who are non-smokers, without any medical
history of CAD, hypertension and diabetes mellitus, and not significantly different
in age between ethnic groups, were also analyzed. The Indian PIA2 allele frequency
still remained significantly higher compared to the Chinese and Malays (results not
shown). The limitation of this study is the lack of angiographically verified CAD
patients to support the notion that the PIA2 allele frequency is associated with the
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disease.
Indian patients undergoing stent placement and who have the PIA2allele may war-
rant closer follow-up after stent placement. In addition, use of intravenous gly-
coprotein IIb/IIIa inhibitors during percutaneous intervention may confer greater
benefits among these patients with the PIA2 allele. It has also been demonstrated
that the platelets of men with the PlA2 allele are more responsive to the effect
of aspirin than the platelets of PIA1 homozygotes( Michelson et. al., 2000). This
could have important implications in the primary prevention setting in deciding
when to start aspirin in Indian subjects who may have other traditional risk factors
for developing coronary artery disease








HT    - Hypertension 
CAD - Coronary Artery Disease 
DM   - Diabetes Mellitus 
SBP - Systolic Blood Pressure 
DBP - Diastolic Blood Pressure 
 
Parameters studied  Chinese Malays Indians 
Number of subjects  316 193 197 
Non-smokers (%) 
69 41 78 
 
Ex-smokers (%) 7 10 3 
Smoking 
 











BMI Mean 23.5 25 24.5 
Medical history          None (%) 87.6 90.6 86 
                                  HT   (%) 9.5 4.7 10.8 
                                  CAD (%) 2.2 3.6 10.5 
                                  DM   (%) 3.8 4.7 6.2 
SBP Mean 123 125 124 
DBP Mean 82 84 83 













    
     PlA1/ PlA1    310    310     PlA1 = 0.99    0.03 
     PlA1/ PlA2    6    5.9     PlA2 = 0.01  
     PlA2/ PlA2    0    0.03   
Malay (n=193)     
     PlA1/ PlA1    190    190     PlA1 = 0.99    0.01 
     PlA1/ PlA2    3    2.9     PlA2 = 0.01  
     PlA2/ PlA2    0    0.01   
Indian (n=197)     
    PlA1/ PlA1    159    159.03     PlA1 = 0.9    0 
    PlA1/ PlA2     36    35.9     PlA2  = 0.1†  
    PlA2/ PlA2    2    2.3   
 
  
† Significantly higher than PlA2 frequencies of Chinese and Malays [Z=5.64; P < 0.001] 
 
Chapter 4
The Factor XIIIa V34L Polymorphism
4.1 Introduction
Blood coagulation FXIII or fibrin stabilizing factor, is the plasma zymogen of trans-
glutaminase and is the last enzyme to be activated in the coagulation pathway. The
presence and normal functional integrity of FXIII is essential for maintaining nor-
mal homeostasis. FXIII covalently cross links fibronectin and thrombospondin to
anchor the blood clots to the site of injury. Activated FXIII is known to cross
link 2-antiplasmin to fibrin (Sakata and Aoki, 1980) to inhibit plasmin and conse-
quently to inhibit fibrinolysis of the fibrin gel (Sakata and Aoki,1981; Mimuro et.
al., 1986). Higher plasma FXIII activity may therefore prevent the generation of
sufficient amounts of plasmin and may also link more 2-antiplasmin to fibrin and
thus cause the formation of a more rigid and stable fibrin gel that is resistant to
fibrinolysis. In addition FXIII can also cross link fibronectin, vitronectin, collagen
and lipoprotein(a) in the extra cellular matrix. Furthermore, it is important in the
stimulation of connective tissue cells and the processes involved in inflammation
and wound healing. Intracellular FXIII exists as a dimer of two FXIIIa subunits,
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whereas the circulating plasma FXIII is composed of two FXIIIa and two FXI-
IIb subunits (Schwartz et. al., 1973). This tetramer is activated in the presence
of thrombin and Ca2+ by separation of the two subunits and cleavage of the 37
amino acid activation peptide from the N terminal of the FXIIIa molecule. The
gene coding for FXIIIa maps to chromosome 6p24-25 and encodes a mature pro-
tein of 731 amino acids (Board et. al., 1998). The B subunit of FXIII comprising
641 amino acids has been assigned to chromosome 1q31-32 (Webb et. al., 1989).
Apart from the actual cross linking reaction, factors that influence the activity of
the FXIII enzyme in plasma include the efficiency of activation and the specificity
of substrate binding. A common G to T polymorphism in codon 34 of exon 2 of
the FXIIIa subunit gene results in the substitution of amino acid valine (GTG) to
leucine (TTG), three amino acids away from the thrombin cleavage site (Anwar
et. al., 1995). The amino acid change at this location might influence the process
of proteolytic activation and FXIII activity. Association studies have investigated
the relationship between FXIII V34L polymorphism and the risk of myocardial
infarction (MI). The majority of these studies have reported that the L34 variant
is likely to have a protective effect in relation to coronary artery disease (Kohler
et. al., 1998; McCormack et. al., 1998; Wartiovaara et. al., 1999; Franco et. al.,
2000; Gemmati et. al., 2001; Reiner et. al., 2002). The V34L polymorphism has
also been correlated with protection against venous thromboembolism (Franco et.
al., 1999; Catto et. al., 1999; Renner et. al., 2000) and increased susceptibility
to intracerebral hemorrhage (Catto et. al., 1998). However there are studies that
reported no association between the L34 allele and risk of myocardial infarction
(Canavy et. al., 2000; Aleksic et. al., 2002). One group reported the lack of as-
sociation between the polymorphism and thromboembolism and with spontaneous
intracranial hemorrhage (Corral et. al., 2000, 2001). Comparison of male and
female patients with MI showed an almost 2 fold higher prevalence of the FXIIIa
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L34 allele in males in another study (Butt et. al., 2002). No association was found
between the V34L variation and myocardial infarction in a recent study carried out
among young MI patients where genetic determinants are assumed to play a ma-
jor role (Atherosclerosis, Thrombosis and Vascular Biology Italian Study Group.
2003). The allele frequencies of the V34L polymorphism in the three ethnic groups
of Singapore (Chinese, Malays and Asian Indians) and its impact on plasma FXIII
activity were determined. The impact of the polymorphism on plasma FXIII ac-
tivity together with two previously reported FXIIIa polymorphisms - P564L and
E651Q (Saha et. al., 2000), were also analyzed in this multiethnic sample.
4.2 Materials and Methods
4.2.1 Study subjects
570 healthy individuals were recruited while undergoing routine annual medical
examinations offered by their employers at the Singapore Anti-Tuberculosis Asso-
ciation Chest and Heart Clinic according to the guidelines mentioned in section
2.1.1.
4.2.2 Genetic analysis
Venous blood was taken from each subject after an overnight fast of at least 10
hours in tubes containing EDTA as anti-coagulant. Genomic DNA from blood was
extracted according the methods of Parzer and Mannhalter, 1991). Polymerase
chain reaction was carried out in 20 microlitre reaction volumes with the primers
sense-5’- catgccttttctgttgtcttc-3’ and antisense-5’-taccttgcaggttgacgccccggggcacta-
3’ (Kangsadalampai and Board, 1998). In the reverse primer, a C to T modification
at the penultimate nucleotide was introduced to create a DdeI restriction enzyme
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Figure 4.1: FXIII V34L genotypes
site in the L34 variant CTTGG to CTTAG , where the T in italic is the poly-
morphic site). The primer modified V34 sequence (CGTAG) abolishes the DdeI
restriction site, thus allowing for genotyping of the G to T transversion. The cy-
cling conditions were as follows: 5 min denaturation at 94 deg C, followed by 35
cycles of 1.4 min of denaturation at 93 deg C, 2.5 min of annealing at 54 deg C
and 2 min extension at 72 deg C followed by a final 10 min extension step at 72
deg C. Overnight digests were carried out with 5U of the restriction enzyme (New
England Biolabs). Digested products were electrophoresed in 3.5% agarose gel and
visualized under UV light by ethidium bromide staining (Figure 4.1).
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4.2.3 Metabolic estimations
Plasma was separated from the venous blood, collected after an overnight fast,
by centrifugation at 2500 rpm for 10 minutes. Aliquot portions were stored at
-20 deg C until use. Plasma FXIII activity was assayed by photometric assay
(Fickenscher et. al., 1991) using the Berichrom FXIII kit (Behringwerke, AG,
Marburg, Germany). Details of this assay have been described earlier (Saha et.
al., 2000). Body mass index (BMI) was calculated as current measured weight in
kilograms divided by the square of height in meters.
4.2.4 Statistical analyses
Allele frequencies were obtained by the gene counting method. The chi-square anal-
yses was used to test for departure of genotype frequencies from Hardy-Weinberg
expectations and the z-test for differences in allele frequency between ethnic groups.
The significance of differences in the mean FXIII activity levels between races and
between genders was determined by the analyses of variance (ANOVA). Analyses of
covariance (ANCOVA) was used to determine the effect of the V34L polymorphism
on FXIII activity in the different ethnic groups with adjustment for significant con-
founders such as age, BMI and smoking. Primarily, the covariates were included
to control for the variability in FXIII activity that was not attributable to genetic
variation. The significance of the sample variance was tested by the p value while
percentage of explained variance (R2 x100) was calculated from the sum of squares.
Linkage disequilibrium was determined using the formula by Hill and Robertson,
1968. Diplotypes were obtained by combining genotype information of the V34L
with P564L and E651Q sites that were previously reported (Saha et. al., 2000).
Mean FXIII activity levels were compared between diplotypes by carrying out the
post hoc multiple comparison using Tukey’s honestly significant difference (HSD)
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test. Statistical significance is defined by p values of 0.05 or less in all analyses.
Due to the skewed distribution of raw FXIII activity levels, they were normalized
by natural logarithm transformation prior to any parametric tests. Analyses were
carried out using SPSS for Windows, Version 11.0 (SPSS Inc, Chicago).
4.3 Results
4.3.1 Frequency distribution
Subject demographics among the three ethnic groups have been presented previ-
ously (Saha et. al., 2000). The allele frequencies of the polymorphism are as shown
in Table 4.1. The distribution is in accordance to a population at Hardy- Wein-
berg equilibrium. The rare allele (L34) frequency is significantly higher (p<0.001)
among Malays (0.08) and Asian Indians (0.08) compared to the Chinese (0.005).
4.3.2 Impact of V34L genotypes on plasma FXIII activity
No significant difference in FXIII activity levels is observed between genders (re-
sults not shown). As such, subjects from both genders are pooled for ethnic com-
parisons. There is significant difference (p<0.0005) in the plasma FXIII activity
among the Indians (148.4%± 35.5)when compared to the Chinese(111.2%±26.7)
and Malays(115.2%±26.1). The effect of FXIII genotypes on FXIII activity are
also presented in Table 4.2. All analyses are carried out with age, BMI and smoking
as covariates whenever they are found to be a significant confounder in the general
linear model. Smoking is a confounding factor among the Chinese males. The as-
sociation of the V34L genotypes with FXIII activity was gender- and ethnic-group
specific as significance is only observed in female subjects who are Asian Indians
(p=0.03) but not in Chinese and Malays. The V34L polymorphism explains 13%
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of the total variation of FXIII activity among the female Indians. In order to de-
termine if there are differences in allele frequencies between the Indian case and
control subjects, one hundred additional subjects who have documented evidence
of myocardial infarction were genotyped. However, no significant difference in the
frequency of the L34 variant is observed (data not shown). As the results of the
P564L and E651Q polymorphisms in the same population had been previously
reported, a three-way ANCOVA to determine if the effect of the V34L variation is
independent of the other polymorphic sites was carried out. It was found that the
association of both V34L (p=0.001) and P564L (p=0.022) with FXIII activity is
independent of each other and that there are no significant interactions between the
3 polymorphic sites. We also determined if there is any pair-wise linkage disequi-
librium between these sites and found weak but significant linkage disequilibrium
between P564L and V34L (∆ = 0.11, p < 0.0005).
In addition, data from all three polymorphisms were pooled to determine their
combined effects on plasma FXIII activity. This was carried out in an ANCOVA
model by using diplotypes, which are basically composite genotype information
from the three polymorphic sites (Table 4.3). In the Chinese, 11 diplotypes are
observed out of 27 theoretically possible combinations from 3 bi-allelic sites. Of
these, 5 were omitted for analyses due to small group size of less than 3 subjects.
Of the six diplotypes that were analyzed, the difference in mean FXIII activity
is significant only between D3 (VV/LL/EE) and D8 (VV/PP/QQ), which have
the lowest and highest FXIII activity, respectively (Table 4.3). This was revealed
by running multiple comparison test using the Tukey’s HSD. It should be noted
that the V34L site is monomorphic in the diplotypes included for analyses in the
Chinese, and thus the significant difference observed can only be due to EE and
PP homozygotes. From this, it is apparent that the VLE haplotype is associated
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with a lowering, while the VPQ haplotype is associated with an elevating effect
on FXIII activity. Haplotype phase could be unambiguously determined from the
two respective homozygous diplotypes. As expected, the homozygous wild type
(D7 bearing two copies of the haplotype VPE) has intermediate activity. Among
the Asian Indians, 13 diplotypes are observed. More diplotypes are expected in
the Indians since there is no significant linkage disequilibrium detected among the
3 polymorphic sites in this ethnic group. Only 2 diplotypes were omitted for anal-
yses due to small group size. D1 was found to have significantly lower mean FXIII
activity level than D10, D11 and D12. One obvious trend here is that the 3 diplo-
types with the highest FXIII activity has in common the V/L34 genotype, which
is associated with elevated FXIII activity when analyzed on its own in this study.
The only other diplotype carrying V/L34 is D2, which bears the L/L564 genotype
that is associated with lowering effect on FXIII activities in a previous study by
Saha et. al., (2000). Hence the simultaneous presence of the opposing effects of
V/L at codon 34 and L/L at codon 564 in subjects would somewhat ’neutralize’
individual effects from each site.
4.4 Discussion
The characteristics and prevalence of the FXIIIa V34L polymorphism had been
examined in different ethnic groups. The frequency of the L34 allele is variable
among different races. It has been reported to range from 25-30% in the Cau-
casian population (Kohler et. al., 1998; Attie-Castro et. al., 2000) and as high
as 40% among the Pima Indians (McCormack et. al., 1998). Earlier the asso-
ciation of two FXIIIa polymorphisms at codon 564 and 651 with FXIII activity
in the ethnic groups in Singapore had been reported(Saha et. al., 2000). This
study is the first report of the association of the V34L polymorphism with FXIII
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activity in three Asian populations. The data shows that plasma FXIII activity
is determined by both ethnic and genetic components. The L34 allele is signifi-
cantly higher among the Asian Indians and Malays than the Chinese. The mean
FXIII levels are significantly higher among the Asian Indians when compared to
the Chinese and Malays. The L34 allele is associated with an increased FXIII
activity among the Indian females. The finding among the Asian Indian subjects
is consistent with earlier reports associating the L34 variant with an increase in
FXIII activity (Kangsadalampai and Board, 1998, Anwar et. al., 1999). It has
been reported in several earlier studies that the L34 allele is associated with a pro-
tective effect against myocardial infarction and other thromoboembolic disorders
(Kohler et. al., 1998; Catto et. al., 1998; Wartiovaara et. al., 1999). Studies have
also been published reporting the higher activity of the recombinant L34 enzyme
variant , which was confirmed by studies evaluating the plasma FXIII activity
from donors with different genotypes (Kangsadalampai and Board, 1998; Anwar
et. al., 1999). Individuals bearing the polymorphism may be capable of producing
higher levels of activated plasma FXIII than those bearing the wild type FXIII but
the presence of the polymorphism may lead to a wasteful generation of activated
FXIII and the ability to promote extensive covalent cross linking of fibrin and fibrin
enzyme complexes may become diminished prematurely. The protective effect of
the L34 allele against coronary artery disease might therefore be explained by the
rapid activation and depletion of FXIII L34, resulting in decreased FXIII available
for stabilization of clots (Trumbo and Maurer, 2000). In an attempt to observe
the net effect of all three polymorphisms in the FXIIIa gene, the contribution of
these polymorphisms by using diplotypes were analyzed. Results obtained from
both single site analyses (Saha et. al., 2000) and the current diplotype approach
is consistent. The P564 allele is associated with elevated mean FXIII activity in
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both approaches. The diplotype approach is considered to be better than analyz-
ing haplotype effects. First, the use of diplotypes obviates the need for haplotype
assignment from genotype information. Despite the robustness of the estimation-
maximization algorithm, errors inevitably arise when it is used to infer haplotypes
from phase-unknown genotype data. The diplotype method therefore avoided such
errors. Second, unlike haplotypes, diplotypes can be directly associated with FXIII
activity without relying on methods such as average excess to apportion the effects
of each constituent haplotypes within a diplotype. The process of estimating av-
erage excess from diploid individuals would in turn generate errors, especially in a
modest sample size such as ours. Hence, using diplotypes for association analysis
with FXIII activity in this instance without the need for any form of inference has
enabled direct interpretation of results.




Distribution of the FXIII V34L polymorphism among the three ethnic groups 
 
χ2 : χ2 -test statistics for testing deviation from Hardy-Weinberg equilibrium 
ns: not significant 






Observed Expected Allele frequencies χ2 
Chinese (n=315)     
V/V 312 312.0 V = 0.995 0.01 (ns) 
V/L 3     3.0 L = 0.005  
L/L 0     0.0   
Malays ( n = 38)     
V/V 32 32.2 V = 0.921 0.28(ns) 
V/L 6     5.5 L = 0.079†  
L/L 0     0.2   
 
Asian Indians (n=217)     
V/V 183 183.4 V = 0.919 0.14 (ns) 
V/L 33   32.2   L = 0.081†  
L/L 1      1.4   





FXIII activity (Mean % ± SD) among V34L genotypes of the three ethnic groups 
 
* Adjusted for Age, BMI and Smoking 
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Table 4.3 
Mean FXIII activity levels (listed in ascending order) among diplotypes. 
 
Allele frequencies in Chinese -  P564:  0.704;  E651: 0.899 (Saha et al 2000) 
Allele frequencies in Indians  -  P564:  0.676;  E651: 0.873 (Saha et al 2000) 
 
a significantly lower than b (p<0.05) 
c significantly lower than d (p<0.05) 
 
Chinese  Malay Indians 
Diplotypes N Mean levels Diplotypes N 
Mean 
levels Diplotypes N 
Mean 
levels 
        VV/LL/EQ D1 5 104.30 c 
        VL/LL/EE D2 5 125.03 c 
VV/LL/EE D3 18 95.04a VV/LL/EE D3 7 98.78 VV/LL/EE D3 14 135.55 
VV/PL/EQ D5 21 100.07 VV/PL/EE D4 10 109.85 VV/PL/EE D4 53 138.39 
VV/PP/EQ D6 27 102.54 VV/PL/EQ D5 3 110.92 VV/PP/EQ D6 18 140.89 
VV/PL/EE D4 105 105.29 VV/PL/EE D9 3 121.53 VV/PP/EE D7 55 147.98 
VV/PP/EE D7 127 116.31 VV/PP/EE D10 10 129.45 VV/PL/EQ D5 20 150.90 
VV/PP/QQ D8 3 126.15b     VL/PL/EE D9 6 151.64 
        VL/PP/EE D10 13 161.62d 
        VL/PL/EQ D11 3 165.73d 




           
VL/PL/EE  1  VL/PP/EE  1  LL/PL/EE  1  
VL/LL/EE  1  VV/PP/EQ  1  VL/LL/EQ  2  
VV/LL/EQ  2  VL/PP/EQ  1      
VL/LL/EQ  1          
VV/PL/QQ  1          
Chapter 5
Mitochondrial DNA 5178 C>A
Polymorphism
5.1 Introduction
Mitochondria are eukaryotic cytoplasmic organelles responsible for oxidative phos-
phorylation. There are numerous mitochondria in each cell, each having 2-10 copies
of mitochondrial DNA (mtDNA) (Johns, 1996). The mtDNA within each cell’s cy-
toplasm are transmitted through the oocyte’s cytoplasm at fertilization and thus
are strictly maternally inherited (Giles et. al., 1980). Human mtDNA is a cir-
cular 16569 bp of double stranded DNA. It is highly compact, and contains only
37 genes: two genes encode ribosomal RNAs (rRNAs), 22 encode transfer RNAs
(tRNAs), and 13 encode polypeptides. All 13 polypeptides are components of the
respiratory chain, including seven subunits of complex I (NADH dehydrogenase-
ubiquinone oxidoreductase), one subunit of complex III (ubiquinone-cytochrome
c oxidoreductase), three subunits of complex IV (cytochrome c oxidase), and two
subunits of complex V (ATP synthetase). Mitochondrial DNA has a very high
mutation rate, and therefore the sequence diversity of mtDNA is marked between
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individuals. When a mutation arises, cells initially contain a mixture of wild-type
and mutant mtDNAs, a state known as heteroplasmy. The quantitative nature
of mtDNA genetics leads to high degree of variability in the inheritance and ex-
pression of heteroplasmic mutations. Therefore, the same mtDNA mutation can
produce markedly different symptoms among members of the same family, in as-
sociation with the chance fluctuation in the percentage of mutant mtDNAs that
each individual inherits. Results of analysis of both blood and muscle specimens
have shown that in all cases blood contained a lower proportion of mutant mtDNA
than muscle (Wong and Lam, 1997). Although the percentage of mutant mtDNA
fluctuates from tissue to tissue, the mutant mtDNA for point mutations is con-
sistently either present or absent in all tissues. Mutations of mitochondrial DNA
have been reported in mitochondrial encephalomyelopathies, cardiomyopathies and
diabetes mellitus (Goto et. al., 1990; Ozawa et. al., 1990; van den Ouweland et.
al., 1992). An analysis of the entire coding region of the mtDNA identified nu-
merous nucleotide substitutions, including the 5178 C to A transversion in the
NADH dehydrogenase subunit 2 (ND2) coding region (Tanaka et. al., 1998). The
substitution of cytosine with adenine at mtDNA 5178 results in an amino acid
change of leucine to methionine (ND2- 237 L/M). The variation was found to be
more frequent among centenarians (0.62) than among healthy blood donors (0.45)
and was therefore proposed to be associated with longevity. Further analysis in
the same study among randomly selected patients suggested that individuals with
mt5178C are more susceptible to adult-onset diseases than those with mt5178A.
The mt5178A was reported to be relatively rare all over the world (Cann et. al.,
1987; Chen et. al., 1995). However, Tanaka et. al., (1998) and Shimokata et. al.,
(2000) reported the high frequency of mt5178A among the Japanese population.
The high frequency of mt5178A among the Japanese population was proposed to
be relevant to the high life expectancy at birth in Japan. In a study among the
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Irish population all individuals were tested negative for the 5178A polymorphism
(Ross et. al., 2001). The mt5178A is linked to Asian haplotypes and has not yet
been reported in the European population (Torroni et. al., 1996). Other polymor-
phisms in the mitochondrial DNA associated with longevity have been described
in the European population (De Benedictis et. al., 1999; Ivanova et. al., 1998).
Further studies have proposed that mt5178A might be associated with longevity,
conferring resistance to adult onset diseases by suppressing obesity and atheroscle-
rosis (De Benedictis et. al., 1999; Ivanova et. al., 1998; Tanaka et. al., 2000).
It has also been postulated that mt5178A genotype decelerates the accumulation
of mtDNA mutations in somatic cells with advancing age (Tanaka et. al., 2000).
Association of the mt5178C>A polymorphism with serum protein fraction levels
has been reported in Japanese females (Kokaze et. al., 2002). The polymorphism
was also shown to influence the effect of smoking on serum protein fraction levels in
middle aged healthy Japanese men (Kokaze et. al., 2003). It has been postulated
that atherosclerosis may be more severe in smokers with the mt5178C genotype
than in mt5178C nonsmokers. The mt5178A genotype was reported to exhibit an
antiatherogenic effect (Matsunaga et. al., 2001; Tanaka et. al., 2000), and to lower
the risk of diabetes mellitus type2 when compared with the mt5178C genotype
(Wang et. al., 2001). The variation was suggested to retard the age dependent
increase in the carotid intima-media thickness in one of the studies (Matsunaga
et. al., 2001). The serum total cholesterol and low density lipoprotein cholesterol
levels have shown a correlation with the mean intimal medial-thickness change
(Yamasaki et. al., 2000). The study by Kokaze et. al., (2001) explored among
the Japanese population, the association between the mt5178C>A variation and
serum lipid levels. It reported that the mutation was associated with triglyceride
levels among females and high density cholesterol levels among males. The present
study is aimed at estimating the frequency of the polymorphism among the three
5.2 Methods 57
ethnic groups of Singapore, namely the Chinese, Malays and Indians. The Singa-
porean Indians are known to have more than three times higher CAD mortality
compared to the Chinese (Hughes et. al., 1990). The associations between the ge-
netic variation and plasma lipid parameters among the three ethnic groups as well
as between healthy subjects and those with documented evidence of atherosclerosis
were examined. This is the first study of the mtDNA 5178C>A variation in the
Asian populations outside Japan.
5.2 Methods
5.2.1 Subjects
A total of 713 healthy individuals comprising 391 Chinese, 129 Malays and 177
Indians were genotyped for the mtDNA 5178C>A variation. They were recruited
randomly from those who attended routine medical examinations at the SATA
Clinic as described in section 2.1.1.
5.2.2 Genotyping and lipid profiles
Venous blood was taken from each subject after an overnight fast of at least 10
hours in tubes containing EDTA as anti-coagulant. Genomic DNA from blood was
extracted according the methods of Parzer and Mannhalter, 1991). Determination
of the genotype was carried out by PCR using sense (5’-CTTAGCATACTCCTCAA
TTACCC-3’) and reverse (5’-CTGAATTCTTCGATAATGGCCCA-3’) primers fol-
lowed by digestion with the restriction enzyme Alu1 as described by Kokaze et.
al.,(2001)(Figure 5.1). The cycling conditions were as follows: Initial denaturation
at 94 deg C for 5 min, followed by 40 cycles of 30 sec of denaturation at 94 deg C,
60 sec of annealing at 60 deg C and 90 sec of extension at 72 deg C followed by a
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Figure 5.1: mtDNA 5178 C>A genotypes
final 10 min extension step at 72 deg C.
The lipid profiles of the subjects - total cholesterol (TC), low-density lipoprotein-
cholesterol (LDL-C), high-density lipoprotein (HDL-C), triglycerides (TG), apolipopro-
teinA1 (apoA1), apolipoproteinB (ApoB), and the lipoprotein(a) [Lp(a)] levels
were also estimated to test for association of this genetic polymorphism with the
plasma lipid levels.
5.2.3 Statistical analyses
The Z test was used to determine differences in allele frequencies among ethnic
groups. To test for effect of genotypes on lipid profiles in healthy individuals,
analysis of covariance (ANCOVA) was carried out with age, body mass index (BMI)
and smoking history as covariates. SPSS version 10 was used in the statistical
analysis. Statistical significance is set at p = 0.05.
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Table 5.1 shows the demographics of the study subjects and allele frequencies in
the three ethnic groups. The allele frequencies showed ethnic variations, with the
A allele being significantly higher (p<0.05) among the Chinese (0.15) in compari-
son to the Malays (0.05) and Indians (0.02). However, the allele frequencies were
not significantly different when healthy subjects were compared with subjects of
the same ethnic group with documented coronary artery disease (data not shown).
The frequency of A allele among all the ethnic groups is lower when compared to
the Japanese population (0.42) (Kokaze et. al., 2001). To examine if there is any
possible association between the mtDNA genotype and age, the population was
stratified into two groups with the age cut off at 50th percentile. Unlike the case
in the Japanese, the study does not show any significant difference in the frequency
of the alleles in relation to age among the three ethnic groups (Table 5.2). Further
stratification into 3 groups by tertiles with comparison of allele frequencies made
between the top and bottom tertiles also failed to reveal any significant relation
with age. As can be seen in Figure 5.2, the cumulative frequencies of individuals
are very close for both genotypes. Despite an observable difference from age 39
to 63, they are comparable at both the lower and higher ends. The data does
not support the notion that this polymorphism is associated with longevity in the
Singaporean context.
Studies exploring the association of the mt5178 C>A variation with plasma lipid
parameters had reported that the triglyceride concentration in females carrying the
A allele was significantly lower than in those carrying the C allele (Kokaze et. al.,
2001). The difference in the triglyceride level between the two genotypes was more
evident among the post-menopausal females than in the pre-menopausal females. It
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was also observed in the same study that the serum high-density lipoprotein choles-
terol level in men carrying mt5178A was significantly higher than in those carrying
mt5178C. In this study, the A allele was found to be significantly associated with
higher plasma apoB levels among the healthy Chinese males (p=0.03), after adjust-
ing for the confounding effects of age, smoking habits and body mass index (Table
5.3). Though not to level of significance, it is noted that the triglyceride levels
are consistently higher in male subjects with the A allele among all the ethnic
groups. No significant association was observed between the allele and triglyc-
eride levels as reported in the earlier study among the Japanese female subjects.
The mechanism by which mtDNA 5178C>A polymorphism influences plasma lipid
levels is not clearly understood. Substitution of leucine with methionine at the
237th amino acid of NADH dehydrogenase may alter the biochemical properties
of NADH dehydrogenase, located in the mitochondrial membrane. The influence
of cigarette smoking on the mitochondrial membrane potential in endothelial cells
and on NADH dehydrogenase activity may explain the difference in sensitivity
to the free radical components in cigarette smoke between the ND-237 Leu/Met
phenotypes (Vayssier-Taussat et. al., 2001). In the current study, no significant
influence of the genetic variation on the lipid levels was detected after stratifying
the subjects into smokers and non smokers. The methionine residues have been
said to possess antioxidant potential and therefore may be involved in the pro-
tective mechanism against endothelial injury leading to atherosclerosis (Levine et.
al., 1996, 1999). Further, since cholesterol synthesis involves components such as
acetyl-CoA in the mitochondria, further investigation into the possible functional
differences arising due to the mt5178 C and A genotypes may shed light on the
mechanism by which the variation influences lipid levels. The finding suggests
that the influences of the variation on the high density lipoprotein and triglyceride
levels reported earlier are not seen among all the three diverse ethnic groups that
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have been studied. The influence of the polymorphism on apoB is seen only among
healthy Chinese males, and therefore could not possibly explain the difference in
incidence of coronary artery disease seen among the three ethnic groups in earlier
studies.
In conclusion, significant ethnic variations in the mitochondrial DNA 5178 C>A
allele frequencies were observed. The polymorphism is associated, in an ethnic, and
gender specific manner with plasma apoB levels in the Singaporean Chinese males.
Further, the effects of this polymorphism are apparently quite different from those
that are reported for a Japanese population (Kokaze et. al., 2001) Further investi-
gation of the functional changes influencing the mitochondrial metabolic pathways
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Table 5.1 
mtDNA 5178 C>A genotype distribution and subject demographics 
 




























Non-smokers (%) 72.0 97.8 45.8 93.8 78.6 98.6 
Ex-smokers   (%) 5.2 0.6 9.4 3.1 2.9 0 
Smokers        (%) 22.7 1.7 44.3 3.1 18.3 1.4 
Age(yrs) 36.4 ± 12.9 34.3 ± 12.4 40.1 ± 9.6 29.7 ± 14.4 41.1 ± 13.3 36.4 ± 12.9 
BMI 23.0 ± 3.8 21.8 ± 3.7 25.6 ± 4.3 23.4 ± 6.3 24.5 ± 4.0 23.0 ± 3.8 
TC (mM) 5.5 ± 1.29 5.4 ± 1.15 5.9 ± 1.22 5.1 ± 1.07 5.6 ± 1.17 5.5 ± 1.29 
HDL-C (mM) 1.28 ± 0.36 1.57 ± 0.43 1.15 ± 0.28 1.47 ± 0.34 1.03 ± 0.25 1.28 ± 0.36 
LDL-C (mM) 3.54 ± 1.31 3.40 ± 1.15 4.26 ± 1.16 3.24 ± 0.92 3.89 ± 1.22 3.54 ± 1.31 
ApoA1 (mg/dl) 139.5 ± 24.5 151.1 ± 24.3 128.8 ± 17.4 148.9 ± 20.6 126.2 ± 21.3 134.1 ± 23.9 
ApoB (mg/dl) 99.8 ± 26.6 88.1 ± 22.4 121.8 ± 26.8 96.9 ± 18.6 121.7 ± 31.2 101.4 ± 25.4 
Lp(a) (mM) 1.91 ± 0.95 2.38 ± 1.1 2.15 ± 0.97 2.98 ± 0.73 2.51 ± 0.93 3.14 ± 0.71 
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Table 5.2 
Association of mtDNA 5178 C/A genotype with age. 
Ethnic groups  Chinese Malays Indians 
 C A Total C A Total C A Total 
Stratified according to 50th Percentile       
Age<50th percentile 
(n)  170 31 201 62 3 65 89 1  90 
Percentage within 
group (%) 85 15 100 95 5 100 99 1 100 
Age ≥50th percentile  162 28 190 59 4 63 85 3 88 
Percentage within 
group (%) 85 15 100 94 6 100 97 3 100 
Tertiles       
1st tertile (n)  131 21 152 32 1 33 50 0 50 
Percentage within 
group (%) 86 14 100 97 3 100 100 0 100 
2nd tertile (n) 96 30 126 47 3 50 63 2 65 
Percentage within 
group (%) 76 24 100 94 6 100 97 3 100 
       3rd  tertile (n) 105 8 113 42 3 45 61 2 63 
Percentage within 
group (%) 93 7 100 93 7 100 97 3 100 
 
50th percentile for Chinese, Malays and Indians are 36, 38 and 39 respectively.  
The age cut off for the tertiles are 31 and 42 
Chi square not significant in all ethnic groups  
 




mtDNA 5178 C>A genotypes and plasma lipids in the male subjects. 
 
 
*TG and Lp(a) were analyzed using log transformation but results are presented here as geometric means.  
 Chinese Malays Indians 
Variables C n = 184 
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n = 93 
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lnTG 0.50 ± 0.57 0.52 ± 0.77 0.904 0.61 ± 0.56 0.87 ± 0.51 0.246 0.67± 0.59 1.09 ± 0.89 0.226 




 1.95 2.97  
ApoA1 




129.6 ± 17.28 
 

























2.49 ± 0.91 3.14 ± 1.73 0.44 
Lp(a)* 
(mg/dl) 6.02 4.05  7.50 9.59  11.06 22.10  





























Figure 5.2: Cumulative age distribution of mt5178C and mt5178A subjects
Chapter 6
Conclusions
Epidemiology has been often viewed as the scientific core of public health. One
widely used definition is “the study of distribution and determinants of health re-
lated states or events in populations and the application of this study to control
health problems” (Last, 1995). Adult chronic disease has become not only a major
public health problem of industrialized countries but also of developing countries.
Cardiovascular disease, cancers, chronic obstructive lung disease and diabetes have
now become a major and growing public health problem worldwide, accounting for
50% of the global mortality burden. Multiple levels of causation of coronary artery
disease are increasingly being explored. The causes of CAD outcomes in popula-
tions can be sought at macroscopic levels, such as in the distribution of wealth in a
society; at the individual level, such as in individual behavior; and at microscopic
levels, such as in cellular and molecular processes. The epidemiological task is to
explore and assemble these different levels of causation, and to draw from them
the implications for public health. Due to factors like abundance, position, origins
and haplotypic patterns, ease of genotyping, allele frequency drift, less mutable na-
ture, recombinational oddities etc, single nucleotide polymorphisms (SNPs) have
emerged as a valuable study focus in genetic analysis. Contemporary and future
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use of SNPs include gene discovery and mapping, candidate polymorphism testing,
diagnostic and risk profiling, prediction response to drugs, homogeneity testing and
design of studies, and physiological genomics.
The advantages of candidate-gene approaches in which plausible links between the
functional effects of candidate polymorphisms and disease outcomes are explored,
cannot be over emphasized. Genetic association studies with functional polymor-
phisms on candidate genes can provide powerful evidence on mechanisms of disease
and potential interventions. Such studies are considerably less prone to confound-
ing than conventional risk-factor epidemiology. The key limitation for association
study is that the actual gene or genes involved in the disease must be tentatively
identified before the analysis can be carried out. However, with the rapid develop-
ment of the Human Genome Project and identification of major variants of human
genes, association studies are becoming important methods of the future genetic
analysis of complex traits and gene-environment interaction. The development of
large scale association methods involving the simultaneous examination of hun-
dreds of thousands of SNPs and corresponding haplotypes across the genome are
providing more and more information. Evidence needs to be integrated from more
studies which are being published in various ethnic groups for these candidate
genes. Given the large number of genes that will be examined in relation to CAD,
many spurious findings are likely to emerge. The most important aspect would
be to evolve the guidelines on synthesizing results, particularly for assessing the
prevalence of gene variants, gene disease associations, and gene-environment and
gene-gene interactions.
The study leading to this thesis has attempted to investigate three candidate genes
in relation to heart disease in Singapore. Singapore provides a rare opportunity
to study genetic epidemiology, due to the presence of three ethnic groups. Studies
on CAD are increasingly relevant in Singapore, being the most important cause
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of mortality. To avoid potential confounding from population stratification, the
controls had been matched with cases for ethnic backgrounds, as well as for fac-
tors such as age and sex etc. The study provides the allele frequency distribution
of the nucleotide variations in three candidate genes for coronary artery disease
among the three ethnic groups. The study on the Factor XIII V34L polymorphism
has explored its relation to plasma Factor XIII activity and has shown interesting
results. Research looking at the possible functional changes due to the variation
are providing insights in to the mechanisms by which the polymorphism influences
plasma Factor XIII activity and the mechanisms involved in the coagulation cas-
cade. GlyproteinIIIa receptor antagonists are potent inhibitors of platelet function
and are being used in the management of coronary artery disease. A better un-
derstanding of the association of the nucleotide variations within the receptor to
the response to drugs would contribute to the emerging discipline of personalized
medicine where the drug dosages are decided on the basis of the ethnic and/or
genetic background. The influence of the mt5178 C>A variation on the plasma
lipid levels is also being explored on a functional basis.
The ability to detect different levels of risk within the population and greater
understanding of etiologic mechanisms are the primary benefits of incorporating
genetics into the existing research on cardiac disease. The insights gained by em-
ploying this framework should ultimately allow for the development of new disease
prevention strategies. The cardiovascular genetics group has currently developed a
microarray-based prototype chip that can allow simultaneous genotyping of close
to 100 SNPs associated with CAD. The concept involves using statistical algo-
rithms to predict the individual’s risk of heart disease. The chosen genetic markers
are found on genes that are known to be involved in pathways that contribute to
atherosclerosis and other abnormalities of the heart, such as lipid metabolism and
haemostasis. The genes analysed in the study leading to this thesis would form a
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part of the genetic database used to develop the statistical algorithms which help
in risk prediction. By utilizing the technologies to maximize scientific insight and
practical application while studying candidate gene SNPs, it is certain that molec-
ular epidemiology will help to produce results that are not only easily distilled
to cogent public health messages, but also contribute to the interventional steps
involved in the management of complex diseases like coronary artery disease.
APPENDIX 1                        70   
 
CAD PATIENT DATA FORM  
  
Name:                                                                                        Date      : 










Height:             cm 
  




Weight:             kg 
  
Hip:             cm 
  
B/P:     Systolic                         mmHg    






Hb        : 
  
Race:                            Chinese [   ]  Malay [   ]    Indian [   ]     Others: _______ 
Dialect Group:            Hokkien [   ]  Cantonese [   ]  Teochew [   ]  Hakka  [   ]                                                        
 Others:_______ 
Alcohol Consumption:        Frequent [   ] Occasional [   ] Non-drinker [   ] 
Smoking status:                   Smoker  [   ] Ex-smoker [   ] Non-smoker  [   ] 
Smoking   : _____ years       No. of sticks/day: __________ 
Ex-smoker: _____ years       No. of sticks/day:  __________          When stopped:  
Fasting status:                   Fasting [   ] Non-fasting [   ] Time of last meal : 
  







       Diabetic 
  
   Hypertension 
  
          CAD 
  





























































































Coronary Grading (No. of vessels with >50% obstruction):  
History of MI:  Number of episodes: ____________   Nil [   ] 
Operation:       Year: ___________    Number of vessels:  _________ 
  
Bruce's protocol:     Level (1-6): _____________ 
 
APPENDIX 2 
Healthy Subject Data Form  
Name:                                                                                        Date      : 










Height:             cm 
  




Weight:             kg 
  
Hip:             cm 
  
B/P:     Systolic                         mmHg   






Hb        : 
  
Race:                                   Chinese   [   ]  Malay       [   ]    Indian [   ]     Others:  
Dialect Group:                    Hokkien [   ]  Cantonese [   ]  Teochew [   ]  Hakka  [   ]   
                                                                                             Others: 
Educational Level:      Occupation: 
Alcohol Consumption:        Frequent [   ] Occasional [   ] Non-drinker  [   ] 
Smoking status:                   Smoker   [   ] Ex-smoker [   ] Non-smoker  [   ] 
Smoking   : _____ years       No. of sticks/day: __________ 
Ex-smoker: _____ years       No. of sticks/day:  __________          When stopped:  
Fasting status:                   Fasting [   ] Non-fasting [   ] Time of last meal: 
  






       Diabetic 
  
   Hypertension 
  
          CAD 
  










































[Adelstein AM (1963)] Some aspects of cardiovascular mortality in South Africa.
Br J Pre Soc Med 17: 29-40
[Aleksic N, Ahn C, Wang YW, et. al. (2002)] Factor XIIIA Val34Leu polymor-
phism does not predict risk of coronary artery disease: the atherosclerosis risk
in communities (ARIC) study. Arterioscler Thromb Vasc Biol 22:348-352
[Anwar R, Stewart AD, Miloszewski KJA, et. al. (1995)] Molecular basis of inher-
ited Factor XIII deficiency: Identification of multiple mutations provides insights
into protein function. Br J Haematol 91:728 -735
[Anwar R, Gallivan L, Edmonds SD, et. al. (1999)] Genotype/Phenotype correla-
tions for coagulation Factor XIII: Specific normal polymorphisms are associated
with high or low Factor XIII specific activity. Blood 93:897-905
[Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group (2003)]
No evidence of association between prothrombotic gene polymorphisms and




[Attie-Castro FA, Zago MA, Lavinha J, et. al. (2000)] Ethnic heterogeneity of the
factor XIII Val34Leu polymorphism. Thromb Haemost 84:601-603
[Balarajan R, Bulusu L, Adelstein AM, et. al. (1984)] Patterns of mortality
among migrants to England and Wales from the Indian subcontinent. BMJ 289:
1185-1187
[Balarajan R, Yuen P (1986)] British smoking and drinking habits: variations by
country of birth. Community Med 8: 237-239
[Barrett-Connor E (1985)] Diabetes and heart disease. In: Diabetes in America :
Diabetes data compiled 1984. National diabetes data group, U.S. Department
of health and human services. XVI 1-41
[Beckles GL, Miller GJ, Kirkwood BR, et. al. (1986)] High total and cardiovascu-
lar disease mortality in adults of Indian descent in Trinidad, unexplained by
major coronary risk factors. Lancet 1298-1301
[Bevilacqua MP, Pober JS, Wheeler ME, et. al. (1985)] Interleukin-1 activation of
vascular endothelium. Effects on procoagulant activity and leukocyte adhesion.
Am J Pathol 121: 394-403
[Bini A, Feonglio JJ, Mesa Tejada R, et. al. (1989)] Identification and distribu-
tion of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclero-
sis. Use of monoclonal antibodies. Arterioscler Thromb 9: 109-121
[Board PG, Webb GC, McKee J, et. al.(1998)] Localization of the coagulation
Factor XIIIa subunit gene (F13A) to chromosome 6p24-25. Cytogenet Cell Genet
48:25-27
[Breslow JL (1996)] Mouse models of atherosclerosis. Science 3;272(5262):685-8
Bibliography 74
[Butt C, Zheng H, Randell E, et. al. (2003)] Combined carrier status of prothrom-
bin 20210A and factorXIII-A L34 alleles as a strong risk factor for myocardial
infarction: Evidence of a gene-gene interaction. Blood 8: 3037-3041
[Canavy I, Henry M, Morange PE, (2000)] Genetic polymorphisms and coronary
artery disease in the south of France. Thromb Haemost 83:212-216
[Cann RL, Stoneking M, Wilson AC, (1987)] Mitochondrial DNA and human evo-
lution. Nature 325:31-36
[Catto AJ, Kohler HP, Bannan S, et. al. (1998)] Factor XIII Val 34 Leu A novel
association with primary intracerebral hemorrhage. Stroke 29:813-816
[Catto AJ, Kohler HP, Coore J, et. al. (1999)] Association of a common polymor-
phism in the Factor XIII gene with venous thrombosis. Blood 93:906-908
[Chadha SL, Kadhakrishnan S, Ramachandran K, et. al. (1990)] Epidemiological
study of coronary heart disease in urban population of Delhi. Indian J Med Res
92: 424-430
[Chen YS, Torroni A, Excoffier L, et. al. (1995)] Analysis of mtDNA variation in
African populations reveal the most ancient of all human continent-specific hap-
logroups. Am J Hum Genet 57:133-149
[Corral J, Gonzalez-Conejero R, Iniesta JA, et. al. (2000)] The FXIII Val34Leu
polymorphism in venous and arterial thromboembolism. Haematologica 85:293-
297
[Corral J, Iniesta JA, Gonzalez-Conejero R, et. al. (2001)] Polymorphisms of
clotting factor modify the risk for primary intracranial hemorrhage. Blood
97:2979-2982
Bibliography 75
[Cotran R, Kumar V, Robbins S. Pathologic basis of disease. 5th edition, (1994)]
[Cushing GL, Gaubatz JW, Nava ML, et. al. (1989)] Quantitation and localiza-
tion of apolipoproteins A and B in coronary artery bypass vein grafts resected
at re-operation. Arterioscler Thromb 9: 593-603
[Cutter JL (1998)] Diabetes Mortality in Singapore, a preliminary study. Singa-
pore Med J.39:311-8
[Cybulsky MI, Gimbrone MA Jr (1991)] Endothelial expression of a mononuclear
leukocyte adhesion molecule during atherogenesis. Science 251:788-791
[Danaraj TJ, Acker MS, Danaraj W, et. al. (1959)] Ethnic group differences in
coronary heart disease in Singapore: an analysis of necropsy records. Am Heart
J 58: 516-526
[Davies MJ (1996)] Stability and instability,two faces of coronary arteriosclerosis.
Circulation 94: 2013-20
[De Benedictis G, Rose G, Carrieri G, et. al. (1999)] Mitochondrial DNA inher-
ited variants are associated with successful aging and longevity in humans.
FASEB J 13:1532-1536
[Di Castelnuovo A, de Gaetano G, Donati MB, et. al. (2001)] Platelet glycopro-
tein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-
analysis. Thromb Haemost 85:626 -33
[de Giovanni JV, Pentecost BL, Beevers DG, et. al. (1983)] The Birmingham
blood pressure school study. Postgrad Med J 59:627-629
[Falk E (1992)] Why do plaques rupture? Circulation 86: (suppl III). III30-III42
Bibliography 76
[Feng D, Lindpaintner K, Larson MG, et. al. (1999)] Increased platelet aggrega-
bility associated with platelet GpIIIa PIA2 polymorphism: The Framingham
Offspring Study. Arterioscler Thromb Vasc Biol 1999;19:1142 -7
[Fickenscher K, Aab A, Stber W (1991)] A photometric assay for blood coagula-
tion Factor XIII. Thromb Haemost 65:535-540
[Friedwald WT, Levy RI, Fredrickson DS, et. al. (1972)] Estimation of the con-
centration of low-density lipoprotein cholesterol in plasma without the use of
the preparative ultracentrifuge. Clin. Chem 18: 499-502
[Fox CS, Sullivan L, D’Agostino RB Sr, et. al. (2004)] The significant effect of di-
abetes duration on coronary heart disease mortality: the Framingham Heart
Study. Diabetes Care 27(3):704-8
[Franco RF, Reitsma PH, Lourenco D, et. al. (1999)] Factor XIII Val34Leu is a
genetic factor involved in the etiology of venous thrombosis. Thromb Haemost
81:676-679
[Franco RF, Pazin-Filho A, Tavella AH, et. al. (2000)] Factor XIII Val34Leu and
the risk of myocardial infarction. Haematologica 85:67-71
[Gemmati D, Serino ML, Ongaro A, et. al.(2001)] A common mutation in the
gene for coagulation factor XIII-A (Val34Leu): a risk factor for primary in-
tracerebral hemorrhage is protective against atherothrombotic diseases. Am J
Hematol 67:183-188
[Giles RE, Blanc H, Cann HM, et. al. (1980)] Maternal inheritance of human mi-
tochondrial DNA. Proc Natl Acad Sci USA 77:6715-6719
[Gimbrone MA , Nagel T, Topper JN. (1997)] Biomechanical activation: an
emerging paradigm in endothelial adhesion biology. J Clin Invest 99:1809
Bibliography 77
[Goodall AH, Curzon N, Panesar M, et. al. (1999)] Increased binding of fibrino-
gen to glycoprotein IIIa proline 33 (HPA-1b, PIA2 Zwb) positive platelets in
patients with cardiovascular disease. Eur Heart J 20: 742-747
[Goto Y, Nonaka I, Horai S (1990)] A mutation in the transfer RNALeu(UUR)
gene associated with the MELAS subgroup of mitochondrial encephalomyopa-
thy. Nature 348: 651-653
[Gotto AM (1997)] Cholesterol management in theory and practice. Circulation
96:4424-4430
[Gupta S, Leatham EW, Carrington D, et. al. (1997)] Elevated chlamydia pneu-
moniae antibodies, cardiovascular events, and azithromycin in male survivors
of myocardial infarction. Circulation 96:404-407
[Hames CG, Rose K, Knawles M, et. al. (1993)] Black-white comparisons of 20-
year coronary heart disease mortality in the Evans County Heart Study. Cardi-
ology 82: 122-136
[Hermanson B, Omenn GS, Kronmal RA, et. al. (1988)] Beneficial six-year out-
come of smoking cessation in older men and women with coronary artery disease.
Results from the CASS registry. N Engl J Med 319: 1365-1369
[Hill WG, Robertson A (1968)] Linkage disequilibrium in finite populations.
Theor Appl Genet 38:226-231
[Hughes K, Lun KC, Yeo PP 1990(b)] Cardiovascular diseases in Chinese, Malays,
and Indians in Singapore. Differences in mortality. J Epidemiology Community
Health 44:24-8
Bibliography 78
[Hughes K, Yeo PPB, Lun KC, et. al. (1990a)] Cardiovascular diseases in Chi-
nese, Malays, and Indians in Singapore. II. Differences in risk factor levels. J
Epidemiol Community Health 44: 29-35
[Ivanova R, Lepage V, Charron D, Schachter F (1998)] Mitochondrial genotype
associated with French Caucasian centenarians. Gerontology 44:349
[Johns D (1996)] Mitochondrial DNA and disease. N Engl J Med 333:638-644
[Kangsadalampai S, Board PG (1998)] The Val34Leu polymorphism in the A sub-
unit of coagulation FactorXIII contributes to the large normal range in activity
and demonstrates that the activation peptide plays a role in catalytic activity.
Blood 92:2766-2770
[Kannel WB, Wilson PW (1995)] An update on coronary risk factors. Med Clin
North Am 79:951-7
[Kastrati A, Schomig A, Seyfarth M, et. al.(1999)] PlA polymorphism of platelet
glycoprotein IIIa and risk of restenosis after coronary stent placement. Circula-
tion 99:1005-10
[Keil JE, Weinrich MC, Keil BW, et. al. (1980)] Hypertension in a population
sample of female Punjabi Indians in Southall. J Epidemiol Community Health
34: 45-47
[Keil JE, Sutherland SE, Knapp RG, et. al. (1993)] Mortality rates and risk fac-
tors for coronary disease in Blacks as compared with White men and women. N
Engl J Med 329: 73-78
[Kim HO, Jin Y, Kickler TS, et. al. (1995)] Gene frequencies of the five major hu-
man platelet antigens in African American, white and Korean populations.
Transfusion 35: 863-7
Bibliography 79
[Kirshenbaum, JM (1992)] Therapy for acute myocardial infarction: an update.
Heart Dis. Stroke 1:211
[Kohler HP, Stickland MH, Ossei-Gerning N, et. al. (1998)] Association of a com-
mon polymorphism in the factor XIII gene with myocardial infarction. Thromb
Haemost 79:8-13
[Kokaze A, Ishikawa M, Matsunaga N, et. al. (2001)] Association of the mito-
chondrial DNA 5178 A/C polymorphism with serum lipid levels in the Japanese
population. Hum Genet 109:521-525
[Kokaze A, Ishikawa M, Matsunaga N, et. al. (2002)] Association of the
longevity-associated mitochondrial DNA 5178 A/C polymorphism with
serum protein fraction levels in healthy Japanese women. Exp Gerontol
37:931-936
[Kokaze A, Ishikawa M, Matsunaga N, et. al. (2003)] Longevity-associated mito-
chondrial DNA 5178 A/C polymorphism influences effects of cigarette smoking
on serum protein fraction levels in Japanese men. Mechanisms of Ageing and
Development 124:765-770
[Last JM (1995)] A Dictionary of Epidemiology, 3rd edition. Oxford University
Press, New York.
[Lau E, Woo J, Cockram CS, et. al. (1993)] Serum lipid profile and its association
with some cardiovascular risk factors in an urban Chinese population. Pathology
25: 344-350
[Laule M, Cascorbi I, Stangl V, et. al. (1999)] A1/A2 polymorphism of glycopro-
tein IIIa and association with excess procedural risk for coronary catheter inter-
ventions: a case-controlled study. Lancet 353: 708-12
Bibliography 80
[Lerner DJ, Kannel WB (1986)] Patterns of coronary heart disease morbidity and
mortality in the sexes: a 26-year follow-up of the Framingham population. Am
Heart J 111: 383-390
[Levine RL, Mosoni L, Berlett BS, et. al. (1996)] Methionine residues as endoge-
nous antioxidants in proteins. Proc Natl Acad Sci USA 93:15036-15040
[Levine RL, Berlett BS, Moskovitz J, et. al. (1999)] Methionine residues may pro-
tect proteins from critical oxidative damage. Mech Ageing Dev 107:323-332
[Libby P, Hansson GK (1991)] Involvement of the immune system in human
atherogenesis: current knowledge and unanswered questions. Lab Invest 64:5-
15
[Libby P (1985)] Molecular basis of acute coronary syndromes. Circulation 91:
2844, 199
[Matsunaga H, Tanaka Y, Tanaka M, et. al. (2001)] Antiatherogenic mitochon-
drial genotype in patients with type 2 diabetes. Diabetes Care 24:500-503
[Mayo O, Stamatoyannopoulos G (1969)] Genetic influences on serum cholesterol
in two Greek villages. Hum Hered 19: 86-99
[McCormack LJ, Kain K, Catto AJ, et. al. (1998)] Prevalence of FXIII V34L in
populations with different cardiovascular risk. Thromb Haemost 80:523-524
[Medalie JH , Kahn HA Neufeld HN,et. al. (1973a)] Five-year myocardial infarc-
tion incidence. II, Association of single variables by age and birth place.. J Chron
Dis 26: 329-349
[Medalie JH, Kahn HA, Neufeld HN, et. al. (1973b)] Myocardial infarction over a
five-year period. I. Prevalence, incidence and mortality experience. J Chron Dis
26: 63-84
Bibliography 81
[McCully KS (1969)] Vascular pathology of homocysteinemia: implications for the
pathogenesis of arteriosclerosis. Am J Pathol 56(1):111-28
[McGill HC Jr, McMahan CA, Herderick EE, et. al. (2000)] Origin of atheroscle-
rosis in childhood and adolescence. JP Am J Clin Nutr 72(5 Suppl):1307S-1315S
[McKeigue PM, Marmot MG (1988a)] Mortality from coronary heart disease in
Asian communities in London]. Br Med J 297: 903
[McKeigue PM, Marmot MG, Adelstein AM, et. al. (1985)] Diet and risk factors
for coronary heart disease in Asians in northwest London. Lancet 2: 1086-1090
[McKeigue PM, Marmot MG, Syndercombe Court YD, et. al. (1988b)] Diabetes,
hyperinsulinaemia, and coronary risk factors in Bangladeshis in east London.
Br Heart J 60: 390-396
[McKeigue PM, Miller GJ, Marmot MG (1989)] Coronary heart disease in South
Asians overseas: a review. J Clin Epidemiol 42: 597-609
[Michelson AD, Furman MI, Goldschmidt-Clermont P, et. al.(2000)] Platelet
GpIIIa PlA polymorphisms display different sensitivities to agonists. Circula-
tion 101: 1013-8
[Mikkelsson J, Perola M, Laippala P, et. al. (2000)] Glycoprotein IIIa PIA1/A2
polymorphism and sudden cardiac death. J Am Coll Cardiol 36: 1317-22
[Miller GJ, Beckles GL, Maude GH, et. al. (1989)] Ethnicity and other character-
istics predictive of coronary heart disease in a developing community: principle
results of the St James survey, Trinidad. Int J Epidemiol 18: 808-817
[Miller GJ, Beckles GLA, Byam NTA, et. al. (1984)] Serum lipoprotein concen-
trations in relation to ethnic composition and urbanization in men and women
of Trinidad, West Indies. Int J Epidemiol 13: 413-421
Bibliography 82
[Miller GJ, Kotecha S, Wilkinson WH, et. al. (1988)] Dietary and other charac-
teristics relevant for coronary heart disease in men of Indian, West Indian and
European descent in London. Atherosclerosis 70: 63-72
[Mimuro J, Kimura S, Aoki N (1986)] Release of alpha 2-plasmin inhibitor from
plasma fibrin clots by activated coagulation factor XIII, Its effect on fibrinolysis.
J Clin Invest 77:1006-1013
[Mukherjee AB, Tribedi BP (1943)] Atheromatous lesions in Bengal. Observar-
tions on 4,000 unselected autopsies. J Indian Med Assoc 12: 285
[Murry CE, Gipaya CT, Bartosek T, et. al. (1997)] Monoclonality of smooth
muscle cells in human atherosclerosis. Am J Pathol 151:697-705
[National Center for Health Statistics,United States (1989)] Washington DC,
DHSS pub, No. (PHS) 89-1232
[Neufeld HN, Goldbourt U (1983)] Coronary heart disease: genetic aspects. Cir-
culation 67: 943-954
[Newman PJ, Derbes RS, Aster RH (1989)] The human platelet alloantigens,
PlA1 and PlA2 are associated with a leucine 33 to proline amino acid polymor-
phism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.
J Clin Invest 83:1778-81
[Nijhuis HGJ, Van der Maesen LJG. (1994)] he philosophical foundations of pub-
lic health: an invitation to debate. J. Epidemiol. Community Health 48:13
[O’Brien KD, McDonald TO, Chait A, et. al. (1996)] Neovascular expression of
E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion
molecule-1 in human atherosclerosis and their relation to intimal leukocyte con-
tent. Circulation 4:672-82
Bibliography 83
[Ockene JK, Kuller LH, Svendsen KH, et. al. (1990)] The relationship of smoking
cessation to coronary heart disease and lung cancer in the Multiple Risk Factor
Intervention Trial (MRFIT ). Am J Public Health 80: 954-958
[Ozawa T, Tanaka M, Sugiyama S, et. al. (1990)] Multiple mitochondrial DNA
deletions exist in cardiomyocytes of patients with hypertrophic or dilated car-
diomyopathy. Biochem Biophys Res Commun 170: 830-836
[Parzer S, Mannhalter C (1991)] A rapid method for the isolation of genomic DNA
from citrated whole blood. Biochem J 273:229-231
[Pittilo RM, Bull HA, Gulati S, et. al. (1990)] Nicotine and cigarette smoking: ef-
fects on the ultrastructure of aortic endothelium. Int J Exp Pathol 71: 573-586
[Rajadurai J, Arokiasamy J, Pasamanickam K, et. al. (1992)] Coronary artery
disease in Asians. Aust NZ J Med 22: 345-348
[Rath M, Niendor A, Reblin T, et. al. (1989)] Detection and quantification of
lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arterioscler
Thromb 9: 579-592
[Reiner AP, Frank MB, Schwartz SM (2002)] Coagulation factor XIII polymor-
phisms and the risk of myocardial infarction and ischaemic stroke in young
women. Br J Haematol 116:376-382
[Renner W, Koppel H, Hoffmann C, et. al.(2000)] Prothrombin G20210A, factor
V Leiden, and factor XIII Val34Leu: Common mutations of blood coagulation
factors and deep vein thrombosis in Austria. Thromb Res 99:35-39
[Report on Registration of Births and Deaths (1994)] Republic of Singapore
1987-1994
Bibliography 84
[Richardson PD, Davies MJ, Born GVR(1989)] Influence of plaque configuration
and stress distribution on fissuring of coronary atherosclerotic plaque. Lancet
941-944
[Ridker PM, Cushman M, Stampfer MJ, et. al. (1997a)] Inflammation, aspirin,
and the risk of cardiovascular disease in apparently healthy men. N Engl J Med
336:973-979
[Ridker P, Hennekens C, Schmitz C, et. al. (1997b)] PIA1/A2 polymorphism of
platelet glycoprotein IIIa and risks of myocardial infarction, stroke and venous
thrombosis. Lancet 349:385 -8
[Rosenfeld ME, Khoo JC, Miller E, et. al. (1991)] Macrophage-derived foam cells
freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins,
promote oxidation of low-density lipoproteins, and contain oxidation-specific
lipid-protein adducts. J Clin Invest 87: 90-99
[Ross OA, McCormack R, Curran MD, et. al. (2001)] Mitochondrial DNA poly-
morphism: its role in longevity of the Irish population. Exp. Gerontol 36:1161-
1178
[Sacks FM, Pfeffer MA, Moye LA, et. al.(1996)] The effect of pravastatin on coro-
nary events after myocardial infarction in patients with average cholesterol levels.
Cholesterol and Recurrent Events Trial investigators. N Engl J Med 335:1001-
1009
[Saha N. (1987)] Serum high density lipoprotein cholesterol, apolipoprotein A-I,
A-II and B levels in Singapore ethnic groups. Atherosclerosis 68(1-2):117-21
[Saha N, Liu Y, Heng CK, et. al. (1994)] Association of factor VII genotype with
plasma factor VII activity and antigen levels in healthy Indian adults and inter-
action with triglycerides. Arterioscler Thromb 14: 1923-1927
Bibliography 85
[Saha N, Christopher EA, Low PS, et. al. (2000)] Racial and genetic determi-
nants of plasma factor XIII activity. Genet Epidemiology 19:440-455
[Saha N, Ton CC, Ghosh MB (1973)] Genetic association in myocardial infarc-
tion. Ethnicity; ABO, Rh, Lea, Xga blood groups; G6PD deficiency; and ab-
normal haemoglobins. J Med Genet 10: 340-344
[Sakata Y, Aoki N (1980)] Cross-linking of Alfa 2-plasmin inhibitor to fibrin by
fibrin-stabilizing factor. J Clin Invest 65:290-297
[Sakata Y, Aoki N (1981)] Significance of cross-linking of Alfa 2-plasmin inhibitor
to fibrin in inhibition of fibrinolysis and in haemostasis. J Clin Invest 69:536-542
[Sandholzer C; Saha N; Kark JD ,et. al. (1992)] Apo(a) isoforms predict risk for
coronary heart disease. A study in six populations. Arterioscler Thromb 12:
1214-26
[Scandinavian Simvastatin Survival Study Group (1994)] Randomized trial of
cholesterol lowering in 4444 patients with coronary heart disease: the Scandi-
navian Simvastatin Survival Study (4S). Lancet 344:1383-1389.
[Schwartz ML, Pizzo SV, Hill RL, et. al. (1973)] Human Factor XIII from plasma
platelets. Molecular weights, subunit structures, proteolytic activation and cross-
linking of fibrinogen and fibrin. J Biol Chem 248:1395 -1407
[Seifert PS, Kazatchkine MD (1988)] The complement system in atherosclerosis.
Atherosclerosis 73: 91-104
[Shaper AG, Pocock SJ, Walker M,et. al. (1987)] Risk factors for ischaemic heart
disease: the prospective phase of the British Regional Heart Study. In : Coro-
nary Heart Disease:Reducing the risk. Heller T, Bailey L, Gott M, Howes M
(Eds.)New York: John Wiley Sons Ltd. 97-106
Bibliography 86
[Shimokata H, Yamada Y, Nakagawa M, et. al. (2000)] Distribution of genetic
disease related genotypes in the National Institute for Longevity Science, Lon-
gitudinal Study of Aging (NILS-LSA). J. Epidemiol 10:S46-S55
[Shepard J, Cobbe SM, Ford I, et. al.(1995)] West of Scotland Coronary Preven-
tion Study Group. N Engl J Med 333:1301-7
[Sicree RA, Tuomilehto J, Zimmet P, et. al. (1988)] Electrocardiographic abnor-
malities amongst Melanesian and Indian men of Fiji: prevalence and associated
factors. Int J Cardiol 19: 27-38
[Silman A, Loysen E, De Graaf W, et. al.(1985)] High dietary fat intake and
cigarette smoking as risk factors for ischaemic heart disease in Bangladeshi male
immigrants in East London. J Epidemiol Community Health 39: 301-303
[Smith EB, Staples EM, Dietz HS, et. al. (1979)] Role of endothelium in seques-
tration of lipoprotein and firbrinogen in aortic lesions, thrombi, and graft pseudo-
intimas. Lancet 2: 812-816
[Stary HC, Chandler AB, Dinsmore RE et. al.(1995)] A definition of advanced
types of atherosclerotic lesions and a histological classification of atherosclerosis.
Circulation 92:1355-74
[Steinberg D (1997)] Oxidative Modification of LDL and Atherogenesis. Circula-
tion 95:1062-1071
[Tanaka M, Gong JS, Zhang J, et. al. (1998)] Mitochondrial genotype associated
with longevity. Lancet 351:185-186
[Tanaka M, Gong JS, Zhang J, et. al. (2000)] Mitochondrial genotype associated
with longevity and its inhibitory effect on mutagenesis. Mechanisms of Ageing
and Development 116:65-76
Bibliography 87
[Tchai BS (1993)] Changes of plasma lipids and biochemical markers for coronary
artery disease in Korea. Ann NY Acad Sci 676: 279-288
[Torroni A, Huoponen K, Francalacci P, et. al. (1996)] Classification of European
mtDNAs from an analysis of three European populations. Genetics 144:1835-
1850
[Treasure CB (1995) ] Beneficial effects of cholesterol-lowering therapy on the
coronary endothelium in patients with coronary artery disease. N Engl Jour-
nal of Med 332:481-7
[Trumbo TA, Maurer MC (2000)] Examining thrombin hydrolysis of the factor
XIII activation peptide segment leads to a proposal for explaining the cardio
protective effects observed with the factor XIII V34L mutation. J Biol Chem
275:20627-20631
[Tuomilehto J, Ram P, Eseroma R, et. al. (1984)] Cardiovascular diseases and di-
abetes mellitus in Fiji: analysis of mortality, morbidity and risk factors. Bull
WHO 62: 133-143
[Uemura K, Pisa Z (1988)] Trends in cardiovascular disease mortality in industri-
alized countries since 1950. World Health Stat Q 41: 155-178
[van den Ouweland JM, Lemkes HH, Ruitenbeek W, et. al. (1992)] Mutation in
mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally
transmitted type II diabetes mellitus and deafness. Nat Genet 5:368-371
[Vayssier-Taussat M, Camilli T, Aron Y, et. al. (2001)] Effects of tobacco smoke
and benzo[a]pyrene on human endothelial cell and monocyte stress responses.
Am J Physiol Heart Circ Physiol 280:H1293-H1300
Bibliography 88
[Vlodaver Z, Kahn HA, Neufeld HN. (1969)] The coronary arteries in early life in
three different ethnic groups. Circulation 39: 541-550
[Walter DH, Schachinger V, Elsner M, et. al.(1997)] Platelet glycoprotein IIIa
polymorphisms and risk of coronary stent thrombosis. Lancet 350:1217-9
[Wander GS, Khurana SB, Gulata R, et. al. (1994)] Epidemiology of coronary
heart disease in a rural Punjab population–prevalence and correlation with
various risk factors. Indian Heart J 46: 319-323
[Wang D, Taniyama M, Suzuki Y, et. al. (2001)] Association of the mitochondrial
DNA 5178A/C polymorphism with maternal inheritance and onset of type 2
diabetes in Japanese patients. Exp Clin Endcrinol Diabetes 109:361-364
[Wartiovaara U, Perola M, Mikkola H, et. al. (1999)] Association of FXIII
Val34Leu with decreased risk of myocardial infarction in Finnish males.
Atherosclerosis 142:295-300
[Webb GC, Coggan M, Ichinose A, et. al. (1989)] Localization of human coagula-
tion Factor XIII B subunit to chromosome bands 1q31-32.1 and restriction frag-
ment polymorphism of the locus. Hum Genet 81:157-60
[Weck KE, Dal Canto AJ, Gould JD, et. al.(1997)] Murine gammaherpesvirus 68
causes large vessel arteritis in mice lacking interferon-gamma responsiveness: a
new model for virus-induced vascular disease. Nature Medicine 3:1346-1353
[Weiss EJ, Bray PF, Tayback M, et. al.(1996) ] A polymorphism of a platelet gly-
coprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J
Med 334:1090-4
[WHO MONICA project (1994)] Myocardial infarction and coronary deaths in the
World Health Organization MONICA project. Circulation 90: 583-612
Bibliography 89
[Wight TN (1989)] Cell biology of arterial proteoglycans. Arteriosclerosis 9: 1-20
[Wong L, Lam C (1997)] Alternative, noninvasive tissues for quantitative screen-
ing of mutant mitochondrial DNA. Clin Chem 43:1241-1243
[Wyndham CH (1982)] Trends with time of cardiovascular mortality rates in the
populations of the RSA for the period 1968 - 1977. S Afr Med J 61: 987-993
[Yamasaki Y, Kodama M, Nishizawa H, et. al. (2000)] Carotid intima-media
thickness in Japanese type 2 diabetic subjects: predictors of progression and
relationship with incident coronary heart disease. Diabetes Care 23:1310-1315
[Yla-Herttuala S, Palinski W, Rosenfeld ME, et. al. (1989)] Evidence for the pres-
ence of oxidatively modified low density lipoprotein in atherosclerotic lesions of
rabbit and man. J Clin Invest 84: 1086-1095
[Yao C, Wu Z, Wu Y (1993)] The changing pattern of cardiovascular diseases in
China. World Health Stat Q 46: 113-118
[Zimmet P, Taylor R, Ram P, et. al. (1983)] Prevalence of diabetes and impaired
glucose tolerance in the biracial (Melanesian and Indian) population of Fiji: a
rural-urban comparison. Am J Epidemiol 118: 673-688
Abstract Factor XIII (FXIII) is a plasma transglutami-
nase that is essential for normal haemostasis and fibrino-
lysis. A few polymorphic sites have been identified in the
gene, one of them being a point mutation (V34L) in exon
2 of the FXIIIa subunit gene leading to an amino acid
change of valine to leucine. We have examined the role of
this polymorphism in relation to plasma FXIII activity in
a total of 532 healthy individuals belonging to two ethnic
groups in Singapore. The frequency of the L34 allele was
significantly higher (P<0.001) among the Asian Indians
(0.08) when compared with the Chinese (0.005). No sig-
nificant difference in frequency of the L34 allele was 
observed between Asian Indian CAD patients and con-
trols. The mean FXIII levels were significantly higher
(P<0.0005) among the Asian Indians (148.4%±35.5) when
compared with Chinese (111.2%±26.7). The L34 variant
was associated with increased FXIII activity among Asian
Indian females. This study shows that both racial and ge-
netic components play a significant role in determining
plasma FXIII activity. The effect of V34L polymorphism
on FXIII activity in the Indian females is independent of
the effects of the P564L and E651Q polymorphic sites in
the FXIIIa gene.
Introduction
Blood coagulation FXIII or fibrin stabilizing factor, is the
plasma zymogen of transglutaminase and is the last en-
zyme to be activated in the coagulation pathway. The
presence and normal functional integrity of FXIII is es-
sential for maintaining normal homeostasis. FXIII cova-
lently cross-links fibronectin and thrombospondin to an-
chor the blood clots to the site of injury. Activated FXIII
is known to cross-link α2-antiplasmin to fibrin (Sakata
and Aoki 1980) in order to inhibit plasmin and conse-
quently to inhibit fibrinolysis of the fibrin gel (Sakata and
Aoki 1981; Mimuro et al. 1986). Higher plasma FXIII ac-
tivity may therefore prevent the generation of sufficient
amounts of plasmin and may also link more α2-antiplas-
min to fibrin and thus cause the formation of a more rigid
and stable fibrin gel that is resistant to fibrinolysis. In ad-
dition FXIII can also cross link fibronectin, vitronectin,
collagen and lipoprotein(a) in the extra cellular matrix.
Furthermore, it is important in the stimulation of connec-
tive tissue cells and the processes involved in inflamma-
tion and wound healing. Intracellular FXIII exists as a
dimer of two FXIIIa subunits, whereas the circulating
plasma FXIII is composed of two FXIIIa and two FXIIIb
subunits (Schwartz et al. 1973). This tetramer is activated
in the presence of thrombin and Ca2+ by separation of the
two subunits and cleavage of the 37-amino-acid activation
peptide from the N-terminus of the FXIIIa molecule.
The gene coding for FXIIIa maps to chromosome
6p24-25 and encodes a mature protein of 731 amino acids
(Board et al. 1998). The B subunit of FXIII, comprising
641 amino acids, has been assigned to chromosome
1q31-32 (Webb et al. 1989). Apart from the actual cross-
linking reaction, factors that influence the activity of the
FXIII enzyme in plasma include the efficiency of activa-
tion and the specificity of substrate binding. A common G
to T polymorphism in codon 34 of exon 2 of the FXIIIa
subunit gene results in the substitution of amino acid va-
line (GTG) to leucine (TTG), three amino acids away
from the thrombin cleavage site (Anwar et al. 1995). The
amino acid change at this location might influence the
process of proteolytic activation and FXIII activity.
Association studies have investigated the relationship
between FXIII V34L polymorphism and the risk of myo-
cardial infarction (MI). The majority of these studies have
reported that the L34 variant is likely to have a protective
effect in relation to coronary artery disease (Kohler et al.
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1998; McCormack et al. 1998; Wartiovaara et al. 1999;
Franco et al. 2000; Gemmati et al. 2001; Reiner et al.
2002). The V34L polymorphism has also been correlated
with protection against venous thromboembolism (Franco
et al. 1999; Catto et al. 1999; Renner et al. 2000) and in-
creased susceptibility to intracerebral hemorrhage (Catto
et al. 1998). However there are studies that reported no as-
sociation between the L34 allele and risk of myocardial
infarction (Canavy et al. 2000; Aleksic et al. 2002). One
group reported the lack of association between the poly-
morphism and thromboembolism and with spontaneous
intracranial hemorrhage (Corral et al. 2000, 2001). Com-
parison of male and female patients with MI showed an
almost twofold higher prevalence of the FXIIIa L34 allele
in males in another study (Butt et al. 2002). No associa-
tion was found between the V34L variation and MI in a
recent study carried out among young MI patients, where
genetic determinants are assumed to play a major role
(Atherosclerosis, Thrombosis and Vascular Biology Ital-
ian Study Group 2003).
In this study we determined the allele frequencies of
the V34L polymorphism in the two ethnic groups of Sin-
gapore (Chinese and Asian Indians) and its impact on
plasma FXIII activity. We also analyzed the impact of the
polymorphism on plasma FXIII activity together with two
previously reported FXIIIa polymorphisms – P564L and
E651Q (Saha et al. 2000) – in this multiethnic sample.
Materials and methods
Study subjects
We studied 532 healthy individuals undergoing routine annual
medical examinations offered by their employers at the Singapore
Anti-Tuberculosis Association Chest and Heart Clinic. Physical
examination and laboratory tests such as blood hemoglobin esti-
mation, urine analysis for albumin and sugar, chest X-ray and rest-
ing electrocardiogram were carried out. Informed consent from all
the subjects was sought prior to their inclusion into the study. In-
formation was also obtained regarding the personal and family
medical history, smoking and drinking habits through question-
naires.
Genetic analysis
Venous blood was taken from each subject after an overnight fast
of at least 10 h in tubes containing EDTA as anti-coagulant. Ge-
nomic DNA from blood was extracted according to the methods of
Parzer and Mannhalter (1991). Polymerase chain reaction was car-
ried out in 20-µl reaction volumes, with the primers: sense 5′-cat-
gccttttctgttgtcttc-3′, and antisense, 5′-taccttgcaggttgacgccccggg-
gcacta-3′ (Kangsadalampai and Board 1998). In the reverse primer,
a C to T modification at the penultimate nucleotide was introduced
to create a DdeI restriction enzyme site in the L34 variant (CTTGG
to CTTAG, where the T in italic is the polymorphic site). The
primer modified V34 sequence (CGTAG) abolishes the DdeI re-
striction site, thus allowing for genotyping of the G to T transver-
sion. Overnight digests were carried out with 5 U of the restriction
enzyme (New England Biolabs). Digested products were electro-
phoresed in 3.5% agarose gel and visualized under UV light by
ethidium bromide staining.
Metabolic estimations
Plasma was separated from the venous blood, collected after an
overnight fast, by centrifugation at 2,500 rpm for 10 min. Aliquot
portions were stored at –20 °C until use. Plasma FXIII activity was
measured by photometric assay (Fickenscher et al. 1991) using the
Berichrom FXIII kit (Behringwerke, Marburg, Germany). Details
of this assay have been described earlier (Saha et al. 2000). Body
mass index (BMI) was calculated as current measured weight in
kilograms divided by the square of height in meters.
Statistical analysis
Allele frequencies were obtained by the gene counting method.
The chi-square (χ2) analysis was used to test for departure of geno-
type frequencies from Hardy-Weinberg expectations and the z-test
for differences in allele frequency between ethnic groups.
The significance of differences in the mean FXIII activity 
levels between races and between genders was determined by 
the analysis of variance (ANOVA). Analysis of covariance
(ANCOVA) was used to determine the effect of the V34L poly-
morphism on FXIII activity in the different ethnic groups, with ad-
justment for significant confounders such as age, BMI and smok-
ing. Primarily, the covariates were included to control for the vari-
ability in FXIII activity that was not attributable to genetic varia-
tion. The significance of the sample variance was tested by the
P value, while percentage of explained variance (R2×100) was cal-
culated from the sum of squares. Linkage disequilibrium was de-
termined by ∆ (Hill and Robertson 1968). Diplotypes were ob-
tained by combining genotype information of the V34L with P564L
and E651Q sites that were previously reported (Saha et al. 2000).
Mean FXIII activity levels were compared between diplotypes by
carrying out the post hoc multiple comparison using Tukey’s hon-
estly significant difference (HSD) test. Statistical significance is
defined by P values of 0.05 or less in all analyses. Due to the
skewed distribution of raw FXIII activity levels, they were nor-
malized by natural logarithm transformation prior to any paramet-
ric tests. Analyses were carried out using SPSS for Windows, ver-
sion 11.0 (SPSS, Chicago).
Results
Frequency distribution
Subject demographics of the two ethnic groups have been
presented previously (Saha et al. 2000). The allele fre-
quencies of the polymorphism are as shown in Table 1.
The distribution is in accordance with a population at
Hardy-Weinberg equilibrium. The rare allele (L34) fre-
quency is significantly higher (P<0.001) among Asian In-
dians (0.08) compared with the Chinese (0.005).
Impact of V34L genotypes on plasma FXIII activity
No significant difference in FXIII activity levels is ob-
served between genders (results not shown). As such, sub-
jects from both genders are pooled for ethnic compar-
isons. There is significant difference (P<0.0005) in the
plasma FXIII activity between the Chinese (111.2%±26.7)
and Asian Indians (148.4%±35.5). The effect of FXIII
genotypes on FXIII activity are presented in Table 2. All
analyses are carried out with age, BMI and smoking as
covariates whenever they are found to be a significant co-
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founder in the general linear model. The association of the
V34L genotypes with FXIII activity was gender- and eth-
nic-specific as significance is only observed in female
subjects who are Asian Indians (P=0.03) but not Chinese.
The V34L polymorphism explains 13% of the total varia-
tion of FXIII activity among the female Indians.
In order to determine if there are differences in allele
frequencies between the Indian case and control subjects,
we genotyped one hundred additional subjects who have
documented evidence of myocardial infarction. However,
no significant difference in the frequency of the L34 vari-
ant is observed (0.081 vs 0.110 in cases, P>0.2). The L34
frequency in the Chinese (0.005) is too low for any mean-
ingful comparison between cases and controls.
In order to examine whether the V34L variation has
any impact on other haemostatic factors, we carried out
ANCOVA of plasma fibrinogen and factor VII coagulant
levels with V34L genotypes. No significant association is
found among both genders of the two ethnic groups (re-
sults not shown).
As we had previously reported results of the P564L
and E651Q polymorphisms in the same population, we
carried out three-way ANCOVA to determine if the effect
of the V34L variation is independent of the other poly-
morphic sites. We found that the association of both V34L
(P=0.001) and P564L (P=0.022) with FXIII activity is in-
dependent of each other and that there are no significant
interactions between the three polymorphic sites. We also
determined if there is any pair-wise linkage disequilib-
rium between these sites and found weak but significant
linkage disequilibrium between P564L and V34L (∆=0.11,
P<0.0005) only in the Chinese population.
In addition, we have pooled data from all three poly-
morphisms to determine their combined effects on plas-
ma FXIII activity. This was carried out in an ANCOVA
model using diplotypes, which are basically composite
genotype information from the three polymorphic sites
(Table 3).
In the Chinese, 11 diplotypes are observed out of 27
theoretically possible combinations from three bi-allelic























































































































































































































































Table 1 Distribution of the FXIII V34L polymorphism among the
two ethnic groups (n.s. not significant)
Genotype Observed Expected Allele χ2a
frequencies
Chinese (n=315)
V/V 312 312.0 V=0.995 0.01 (n.s.)
V/L 3 3.0 L=0.005
L/L 0 0.0
Asian Indians (n=217)
V/V 183 183.4 V=0.919 0.14 (n.s.)
V/L 33 32.2 L=0.081b
L/L 1 1.4
a χ2-test statistics for testing deviation from Hardy-Weinberg equi-
librium
b Significantly higher than Chinese
group size of less than three subjects. Of the six diplo-
types that were analyzed, the difference in mean FXIII ac-
tivity is significant only between D3 (VV/LL/EE) and D8
(VV/PP/QQ), which have the lowest and highest FXIII
activity, respectively (Table 3). This was revealed by run-
ning a multiple comparison test using the Tukey’s HSD. It
should be noted that the V34L site is monomorphic in the
diplotypes included for analysis in the Chinese, and thus
the significant difference observed can only be due to EE
and PP homozygotes. From this, it is apparent that the
VLE haplotype is associated with a lowering, while the
VPQ haplotype is associated with an elevating effect on
FXIII activity. Haplotype phase could be unambiguously
determined from the two respective homozygous diplo-
types. As expected, the homozygous wild type (D7 bear-
ing two copies of the haplotype VPE) has intermediate ac-
tivity.
Among the Asian Indians, 13 diplotypes are observed.
More diplotypes are expected in the Indians since there is
no significant linkage disequilibrium detected among the
three polymorphic sites in this ethnic group. Only two
diplotypes were omitted for analysis due to small group
size. D1 was found to have significantly lower mean FXIII
activity level than D10, D11 and D12. One obvious trend
here is that the three diplotypes with the highest FXIII ac-
tivity has in common the V/L34 genotype, which is asso-
ciated with elevated FXIII activity when analyzed on its
own in this study. The only other diplotype carrying V/L34
is D2, which bears the L/L564 genotype that is associated
with a lowering effect on FXIII activities in our previous
study (Saha et al. 2000). Hence the simultaneous presence
of the opposing effects of V/L at codon 34 and L/L at
codon 564 in subjects would somewhat ‘neutralize’ indi-
vidual effects from each site.
Discussion
The characteristics and prevalence of the FXIIIa V34L
polymorphism had been examined in different ethnic
groups. The frequency of the L34 allele is variable among
different races. It has been reported to range from 25 to
30% in the Caucasian population (Kohler et al. 1998; Attie-
Castro et al. 2000) and as high as 40% among the Pima
Indians (McCormack et al. 1998). The L34 allele is sig-
nificantly higher among the Asian Indians than the Chi-
nese.
Earlier we had reported the association of two FXIIIa
polymorphisms at codon 564 and 651 with FXIII activity
in the Singapore Chinese and Indians (Saha et al. 2000).
This study is the first report of the association of the V34L
polymorphism with FXIII activity in two Asian popula-
tions. Our data shows that plasma FXIII activity is deter-
mined by both ethnic and genetic components.
The mean FXIII levels are significantly higher among
the Asian Indians when compared with the Chinese. The
L34 allele is associated with an increased FXIII activity
among the Indian females. The finding among the Asian
Indian subjects is consistent with earlier reports associat-
ing the L34 variant with an increase in FXIII activity
(Kangsadalampai et al. 1998; Anwar et al. 1999).
It has been reported in several earlier studies that the
L34 allele is associated with a protective effect against MI
and other thromoboembolic disorders (Kohler et al. 1998;
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Table 3 Mean FXIII activity levels (listed in ascending order) among diplotypes. Allele frequencies in Chinese: P564, 0.704; E651,
0.899; allele frequencies in Indians: P564, 0.676; E651, 0.873 (Saha et al. 2000)
Chinese Asian Indians
Diplotypes n Mean FXIII Diplotypes n Mean FXIII 
activity levels (%) activity levels (%)
VV/LL/EQ D1 5 104.30 c
VL/LL/EE D2 5 125.03 c
VV/LL/EE D3 18 95.04a VV/LL/EE D3 14 135.55
VV/PL/EQ D5 21 100.07 VV/PL/EE D4 53 138.39
VV/PP/EQ D6 27 102.54 VV/PP/EQ D6 18 140.89
VV/PL/EE D4 105 105.29 VV/PP/EE D7 55 147.98
VV/PP/EE D7 127 116.31 VV/PL/EQ D5 20 150.90
VV/PP/QQ D8 3 126.15b VL/PL/EE D9 6 151.64
VL/PP/EE D10 13 161.62 d
VL/PL/EQ D11 3 165.73 d
VL/PP/EQ D12 4 184.79 d
Excluded from analysis:
VL/PL/EE 1 LL/PL/EE 1




aSignificantly lower than b (P<0.05)
cSignificantly lower than d (P<0.05)
Catto et al 1998; Wartiovaara et al. 1999). Studies have
also been published reporting the higher activity of the re-
combinant L34 enzyme variant, which was confirmed by
studies evaluating the plasma FXIII activity from donors
with different genotypes (Kangsadalampai and Board
1998; Anwar et al. 1999). Individuals bearing the poly-
morphism may be capable of producing higher levels of
activated plasma FXIII than those bearing the wild-type
FXIII, but the presence of the polymorphism may lead to
a wasteful generation of activated FXIII and the ability to
promote extensive covalent cross-linking of fibrin and
fibrin enzyme complexes may become diminished prema-
turely. The protective effect of the L34 allele against coro-
nary artery disease might therefore be explained by the
rapid activation and depletion of FXIII L34, resulting in
decreased FXIII available for stabilization of clots (Trumbo
and Maurer 2000). In the Singaporean population, how-
ever, we found no significant difference in the L34 fre-
quency between CAD cases and healthy controls in the
Asian Indians. The protective effect of L34 allele in the
Chinese population is difficult to assess due to its ex-
tremely low frequency of 0.005.
In an attempt to observe the net effect of all three poly-
morphisms in the FXIIIa gene, we analyzed the contribu-
tion of these polymorphisms by using diplotypes. Results
obtained from both single-site analysis (Saha et al. 2000)
and the current diplotype approach is consistent. The P564
allele is associated with elevated mean FXIII activity in
both approaches.
We believe that using the diplotype approach in our
context is better than analyzing haplotype effects. First,
the use of diplotypes obviates the need for haplotype as-
signment from genotype information. Despite the robust-
ness of the estimation-maximization algorithm, errors in-
evitably arise when it is used to infer haplotypes from
phase-unknown genotype data. The diplotype method there-
fore avoided such errors. Second, unlike haplotypes, diplo-
types can be directly associated with FXIII activity with-
out relying on methods such as average excess to appor-
tion the effects of each constituent haplotypes within a
diplotype for heterozygous subjects. The process of esti-
mating average excess from diploid individuals would in
turn generate errors, especially in a modest sample size
such as ours. Hence, using diplotypes for association
analysis with FXIII activity in our case without the need
for any form of inference has enabled direct interpretation
of results.
In conclusion, we observed significant difference in al-
lele frequencies among the two ethnic groups in Singa-
pore. Although there is a clear effect of FXIII V34L geno-
type on the FXIII-specific activity, we did not observe a
direct correlation between the V34L genotype and its ac-
tivity in relation to coronary artery disease.
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Abstract
Background: Polymorphisms of the glycoprotein IIIa receptor have been shown to be associated with differences in platelet
A2
aggregability. The PI variant of the polymorphism has been reported to be an inherited risk factor for acute coronary events. Although
the allele frequency of this polymorphism is well documented in Caucasian populations, studies involving Asian Indians, Malays and
Chinese are lacking. We studied 706 random male individuals to determine the genotypic distribution of this polymorphism in Singapore.
Methods: Male subjects included in this study were drawn from those undergoing routine annual medical examinations offered by their
employers. Venous blood was obtained from these patients after an overnight fast and from which genomic DNA was extracted.
Genotyping was carried out by polymerase chain reaction (PCR) followed by digestion with restriction enzyme NciI. Personal and family
medical history of the subjects were also taken. Results: The genotype distribution of the individuals studied was in accordance to a
A2population at Hardy Weinberg equilibrium. The frequency of the PI allele was 0.1, 0.01 and 0.01 in the Indians, Malays and Chinese,
A2
respectively. The differences in frequencies of the PI variant are significant among different ethnic groups (P,0.001 for Indians vs.
A2Chinese and Indians vs. Malays). Conclusions: We observed a significantly higher frequency of the PI allele among Indians relative to
the Chinese and Malays in Singapore. The effect of this genotype may partially explain the higher rate of ischaemic heart disease seen
among Indians compared to the Chinese and Malay ethnic groups.
 2003 Elsevier Ireland Ltd. All rights reserved.
Keywords: Ethnic variation; Ischaemic heart disease; Coronary artery disease
1 . Introduction Singapore are at a higher risk of developing coronary
artery disease (CAD) compared to their other ethnic
Singapore is a tropical island nation with a land counterparts. In the Singapore Cardiovascular Cohort
2
area of 648 km . The people of Singapore are from Study, Lee et al. [1] found that Indian males had the
diverse ethnic origins, with the majority comprising highest risk of developing CAD with a hazard ratio of
Chinese, Malays and Indians. The Chinese make up 3.1 when compared to Chinese and 3.4 when com-
the majority of the population in Singapore, account- pared to Malays. In another study by Hughes et al.
ing for 77%, while the Malays account for 14% and [2], Indians in Singapore had higher mortality from
the Indians account for 8%. CAD when compared to their Chinese and Malay
Numerous studies have shown that Indians in counterparts. The age standardized relative risks of
Indians when compared to Chinese males was 3.8
and 3.4 for females [2]. The higher mortality could*Corresponding author. Tel.: 165-6772-5708; fax: 165-6774-2796.
E-mail address: paehck@nus.edu.sg (C.K. Heng). not be explained by risk factors such as cigarette
0167-5273/03/$ – see front matter  2003 Elsevier Ireland Ltd. All rights reserved.
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smoking, blood pressure and serum cholesterol [3]. groups found in Singapore, namely the Chinese,
The authors speculated that the increased risk found Malays and Asian Indians.
A2
among Indians could be in part explained by the We therefore investigated the PI allele frequency
higher prevalence of diabetes mellitus [3]. Another among the ethnic groups in Singapore and whether
A2
study examining diabetic patients in Singapore re- the differences in PI allele frequency could account
ported that Indian diabetics were more likely to die for the increased incidence of ischaemic heart disease
from CAD disease when compared to their Chinese seen among Indians.
counterparts [4].
Since traditional risk factors alone are unable to
explain this increased risk seen among Indians, we 2 . Methods
set out to examine various genetic factors that may
offer an explanation to this increased predisposition 2 .1. Subjects
towards development of CAD. One of these possible
genetic variations is the polymorphism of the We studied 706 random male individuals. Subjects
glycoprotein receptor (GpIIb / IIIa) on platelets. included for this study were drawn from those
Platelets play an integral role in the pathogenesis undergoing routine annual medical examinations
of coronary thrombosis. GpIIb / IIIa binds fibrinogen offered by their employers, at the Singapore Anti-
and allows platelets to form links that enhances Tuberculosis Association Chest and Heart Clinic.
platelet aggregation. GpIIIa is the beta subunit of this Physical examinations and laboratory tests such as
receptor and is also found on the vitronectin receptor. blood hemoglobin estimation, urine analysis for
A single nucleotide T to C transition at position albumin and sugar, chest X-ray and resting electro-
1565 in Exon 2 of the gene encoding GpIIIa leads to cardiogram were carried out. Verbal informed consent
a common diallelic polymorphism Leu-33-Pro [5]. from all the subjects was sought prior to their
A2Persons with the PI allele therefore have a proline inclusion into this study. Information was also ob-
A1
at this position while patients with only the PI tained regarding the personal and family medical
allele have leucine at this position; the substitution is history, smoking and drinking habits through ques-
associated with an increased binding of fibrinogen to tionnaires. Subject demographics are shown in Table
the platelet GpIIb / IIIa receptor [6]. 1.
The allele frequency of this polymorphism has
been well documented in Caucasian populations 2 .2. Laboratory procedures
[7,8]. However, there have been no studies examining
this polymorphism among the three major ethnic Venous blood was taken from each subject after an
Table 1
Demographics of the male study subjects
Ethnic groups Chinese Malays Indians
Number of subjects studied 316 193 197
Smoking Non-smokers (%) 69 41 78
Ex-smokers (%) 7 10 3
Smokers (%) 24 49 19
Age Mean6SD 41.4615.6 38.869.6 41.7613.3
BMI Mean6SD 23.563.6 25.164.2 24.564.3
Medical history None (%) 87.6 90.6 86.0
HT (%) 9.5 4.7 10.8
CAD (%) 2.2 3.6 10.5
DM (%) 3.8 4.7 6.2
SBP Mean6SD 123612 125613 124618
DBP Mean6SD 82610 84611 83611
Medical history (MH) based on answers from self-questionnaire form. CAD, coronary artery disease; HT, hypertension; DM, diabetes mellitus (includes
diet control, insulin and non-insulin dependent); BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure.
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A1 A2
overnight fast of at least 10 h in tubes containing (PI /PI ) and two individuals were homozygous
A2 A2EDTA as anti-coagulant. Genomic DNA from blood for the PI allele. The PI allele frequency was
was extracted according the methods of Parzer et al 10% in the Indians. This was significantly higher than
A2[9]. Polymerase Chain Reaction was carried out in 20 the Chinese and Malays for whom the PI frequency
was only 1%.ml reaction volumes with the primers Sense: 59-
TCTGATTGCTGGACTTCTCTTTG-39 and Anti-
sense: 59-TCTCTCCCCGCAAAGAGTCC-39. Over-
4 . Discussionnight digest were conducted with 5 U of the restric-
tion enzyme NciI (New England Biolabs) in 20 ml of
The major finding of this study was the signifi-amplicons. Digested products were electrophoresed in
A2
cantly higher prevalence of the PI allele among3.5% agarose gel and visualized under UV light by
Indians, which was approximately 10 times higherethidium bromide staining.
A2
compared to the Chinese. The PI allele frequency
2 .3. Statistical analysis among Indians in this study is close to Caucasian
populations [7,8].
2 A2The x analysis was used to test for Hardy– The marked difference in the frequency of the PI
Weinberg equilibrium and the z-test for differences in allele between the ethnic Indians compared to the
allele frequency between ethnic groups. A P-value of Chinese and Malays in Singapore may have im-
0.05 or less was considered to indicate statistical portant clinical implications. Various studies have
significance. Analysis was performed using SPSS shown increased risk of coronary artery disease in
A2(version 11.0) statistical software (SPSS Inc, relation to the PI allelic variant of the GpIIIa
Chicago). receptor.
A case-control study by Weiss and colleagues [8]
A1 /A2found an association of the PI polymorphism
3 . Results with acute coronary thrombosis, particularly in pa-
tients who were under the age of 60. The Framin-
The genotypic distributions among the three major gham Offspring Study [10] has also demonstrated
ethnic groups are shown in Table 2. The distribution heightened platelet aggregability among patients with
was in accordance to a population at Hardy–Wein- this polymorphism. Another study [11] demonstrated
A2berg equilibrium. a higher proportion of the PI allele among subjects
Among the 197 Indians studied, 159 were homo- presenting with sudden cardiac death and evidence of
A1
zygous for the PI allele, 36 were heterozygous acute coronary thrombosis on autopsy in Finland.
Table 2
Genotypic frequency among persons studied
2Genotype Observed Expected Allele frequencies x
Chinese (n5316)
A1 A1 A1PI /PI 310 310 PI 50.99 0.03
A1 A2 A2PI /PI 6 5.9 PI 50.01
A2 A2PI /PI 0 0.03
Malay (n5193)
A1 A1 A1PI /PI 190 190 PI 50.99 0.01
A1 A2 A2PI /PI 3 2.9 PI 50.01
A2 A2PI /PI 0 0.01
Indian (n5197)
A1 A1 A1PI /PI 159 159.03 PI 50.9 0
A1 A2 A2 aPI /PI 36 35.9 PI 50.1
A2 A2PI /PI 2 2.3
a A2Significantly higher than PI frequencies of Chinese and Malays. [Z55.64; P,0.001].
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A2Investigators have also demonstrated that individ- these patients with the PI allele. It has also been
A2A2 demonstrated that the platelets of men with the PIuals with the PI allele have a higher risk of
allele are more responsive to the effect of aspirin thanrestenosis after coronary stent placement and are also
A1the platelets of PI homozygotes [17]. This couldat a higher risk of sub-acute coronary stent throm-
A2 have important implications in the primary preventionbosis [12]. Subjects who possessed the PI allele
setting in deciding when to start aspirin in Indianhad a 5-fold increase in the occurrence of coronary
subjects who may have other traditional risk factorsstent thrombosis [13].
for developing coronary artery disease. FurtherThere have also been studies that failed to demon-
studies are necessary in this area.strate an association of coronary thrombosis with the
A2PI allele [14,15]. However, a recent meta-analysis
[16] reviewing 34 studies for coronary artery disease
5 . Conclusionand six studies for re-stenosis after percutaneous
intervention, (a total of 9095 cases and 12508 con-
We observed a significantly higher frequency oftrols) found a significant but weak association of the
A2A2 the PI allele among Indians relative to the ChinesePI allele with overall cardiovascular disease. High-
and Malays in Singapore. The effect of this genotypeer risks were identified however, among less
may partially explain the higher rate of CAD seenheterogeneous subgroups mainly the young and for
among the Indians, which could not be explained byre-stenosis among patients who had received percuta-
traditional risk factors such as cigarette smoking,neous intervention and stent placement.
blood pressure and serum cholesterol.The increased prevalence of this allele among
Indians could possibly contribute towards their higher
risk of developing coronary heart disease when
R eferencescompared to their Chinese and Malay counterparts.
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